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Tremendous efforts have been made in developing mediatorless glucose 
biosensors because of the potential hazards of mediator-based glucose sensing 
methods. However, most of these studies which employed tedious and lengthy 
preparation procedures, failed to detect the entire pathophysiological glucose 
range, or lacked systematic analysis of sensor performance. Therefore, the aim 
of this study was to develop simple, cost-effective and advanced strategies for 
constructing mediatorless electrochemical glucose biosensors based on the 
usage of 3-aminopropyltriethoxysilane (APTES), glucose oxidase (GOx) and 
carbon-based nanomaterials (carbon nanotubes or graphene). In addition, the 
developed glucose biosensors could precisely detect glucose in the diabetic 
pathophysiological range of 1-30 mM and would be free from interference. 
In the first experiment, the concentration effect of APTES on the 
electrocatalysis of three mediatorless glucose sensing formats (with and 
without using multi-walled carbon nanotubes (MWCNTs)) was studied. It was 
indicated that the concentration of APTES considerably affected the glucose 
sensing results of the three formats in different patterns. This study provided a 
guided insight into the optimization of APTES-based chemistry applied in 
electrochemical glucose biosensor. 
    In the second experiment, a graphene-based mediatorless glucose biosensor 
was constructed by covalent binding GOx to an APTES-graphene 
functionalized glassy carbon electrode (GCE). This biosensor was able to 
detect 1-30 mM glucose at -0.45 V (vs. Ag/AgCl) and its anti-interference 
capability was also demonstrated. This strategy was the first to apply APTES 
in dispersing and functionalizing graphene for the preparation of mediatorless 
vii 
 
glucose biosensor. Furthermore, the excellent production reproducibility of 
this strategy may be beneficial for the mass production of glucose biosensor. 
    In the third experiment, a rapid and highly simplified strategy for the 
immobilization of GOx on GCE surface in a leach-proof pattern was proposed. 
Besides its superior performance on glucose sensing, the constructed biosensor 
was able to preserve its initial activity for at least 4 weeks when stored at room 
temperature in dry state. Additionally, this strategy was the most rapid method 
to prepare a robust and stable glucose biosensor compared to the reported 
methods so far. 
    In the last experiment, MWCNT- and graphene-based glucose biosensors 
were prepared and the glucose sensing performance of MWCNTs and 
graphene was compared for the first time. The cyclic voltammogram showed 
that the direct electron transfer between GOx and GCE surface was only 
observed on the MWCNT-based biosensor, which may be attributed to 
shortened tunneling distance facilitated by the unique structure of MWCNTs. 
The results of this experiment suggested that graphene might not be more 
advanced than CNTs in developing biosensors. 
    In conclusion, this study proposes several highly convenient and stable 
mediatorless electrochemical glucose biosensing strategies for blood glucose 
monitoring. Some of the strategies are proved to be suitable for continuous 
glucose monitoring owing to their high stability and excellent anti-biofouling 
capability. This study may be practically beneficial to the fabrication of 
various mediatorless biosensors for determining analytes of interest. Moreover, 
the systematic investigation of sensor performance in this study should 
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Chapter 1 Introduction 
    The human body naturally tightly regulates blood glucose levels within the 
normal range of 4-8 mM. Nevertheless, a persistently high level above the 
normal range is referred to as diabetes mellitus, which is a disease related to 
failure of blood sugar regulation. Additionally, diabetes is incurable but 
manageable. Therefore, maintaining the blood glucose level within the normal 
range is essential for the healthcare of diabetics by avoiding diabetes-
associated complications such as kidney damage, blindness, neuropathy, 
adverse effect on circulatory system, amputations, etc. Indeed, diabetes has 
been declared as a global epidemic by World Health Organization owing to its 
unprecedented increase worldwide. Presently, there are about 285 million 
diabetics, while the number is anticipated to multiply by 1.54 folds by the end 
of 2030 [1]. Also, there are about 3.96 million deaths per year caused by 
diabetes, which is about 6.8% of the mortality in the age group of 20-79 years 
[2]. Moreover, diabetes monitoring and management is a heavy financial 
burden for the society as approximately 11.6% of the total global healthcare 
expenditure in 2010 (estimated to be US$ 376 billion) was spent on diabetes. 
It is expected that the spending on treating and preventing diabetes and 
associated complications will increase to US$ 490 billion by 2030 [3]. 
As mentioned, regular blood glucose monitoring (BGM) is a key 
requirement for diabetics. Actually, self-glucose monitoring should be used in 
patients on intensive insulin therapy at least three times daily. About 10 billion 
glucose assays are performed worldwide yearly. Therefore, there have been 
continuously increasing research efforts in the area of BGM as shown by the 
tremendous increase in the number of articles published in the previous 
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decades (Fig. 1-1). Notably, the market of blood glucose monitoring device 
(BGMD) accounts for about 85% of the total biosensors market [4]. Such a 
huge market is monopolized by a few diagnostic companies such as Abbott, 
Roche Diagnostics, Bayer, Minimed and LifeScan [5]. Despite their various 
features, most commercial BGMDs measure blood glucose concentrations 
based on the electrochemical redox reaction occurring between the enzyme 
and the substrate (i.e. glucose). More specifically, artificial electron mediator 
is employed in all of the commercial products. 
 
Fig. 1-1. Number of articles published in the past few decades pertaining to 
blood glucose monitoring. Data was taken on Nov 21, 2012 
fromwww.scopus.com using “blood glucose monitoring” in the advanced 
search option. 
 
    However, there are several problems in the mediator-based devices such as 
the toxicity [4] and leakage of the mediator [6]. To overcome these challenges 
is especially important to the development of implantable devices. In addition, 
the active mediator can easily interact with some of the interfering substances 
coexisting in the blood even at a low potential applied to detect glucose [4]. 
As a result, the safety, accuracy and reliability of blood glucose measurement 
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are badly compromised. Therefore, a mediatorless glucose sensing strategy 
that can selectively detect glucose without being interfered by the electroactive 
substances will be an ideal solution to overcome the shortcomings of the 
traditional mediator-based devices. Moreover, the development of accurate, 
cost-effective, and safe mediatorless glucose sensing strategies is of great 
economic importance. During the past decade, mediatorless glucose 
biosensors have been extensively developed based on the utilization of carbon-
based nanomaterial (e.g., carbon nanotubes (CNTs) and graphene), metal 
nanoparticles (NPs) and other materials. The subsequent sections provide a 
brief overview of the mediator-based devices and more attention will be given 
to the latest development of mediatorless-based glucose sensing strategies. 
1.1 Traditional blood glucose monitoring in diabetes: overview 
In this section, some of the essential techniques behind traditional BGMDs 
are introduced. These techniques include the glucose determination methods, 
enzymes used in BGMDs and the glucose sensing principle of mediator-based 
devices. The limitations of mediator-based devices are also discussed. 
However, the other aspects of the techniques used in BGMDs (such as glucose 
limiting membrane, test strip design, etc.) are not covered in this section since 
they are not the research emphasis in this thesis. The comprehensive 
discussion of the techniques applied in commercial BGMDs can be found in 
many review articles [5, 7-9]. 
1.1.1 Methods used for glucose detection in BGM: electrochemistry 
versus other methods 
A wide range of diversified analytical methods such as high performance 
liquid chromatography (HPLC) [10], fluorescence [11-14], infrared (IR) [15], 
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UV-visible (photometry) [16-19] and nuclear magnetic resonance (NMR) 
spectroscopy [20] have been reported for glucose monitoring. Among these 
methods, HPLC, fluorescence and UV-visible spectroscopy can provide 
glucose quantification information with different sensitivities, while IR and 
NMR spectroscopy are normally used for offering structural information of 
glucose (especially when glucose is mixed with other types of sugars) rather 
than detecting its concentration. The advantages and limitations (or challenges) 
of these techniques in glucose sensing are listed in Table 1-1.  
Regarding the glucose sensing in commercial BGMDs, two methods are 
mainly employed, which are photometry and electrochemistry. Indeed 
photometric glucose sensors preceded the electrochemical sensors. The 
principle of a photometric glucose sensor is based on the enzymatically-
catalyzed electron transfer from glucose to light-absorbing dye molecules and 
the subsequent reflectance measurement [8]. Nevertheless, since reflectance 
measurement request the exclusion of red blood cells and large assayed area of 
at least a few square millimeters [8], electrochemical glucose sensors are 
prevailingly used due to their ability to overcome the shortcomings of 
photometric devices. Furthermore, compared to the devices based on the 
above methodologies, electrochemical glucose sensors are preferable as they 






Table 1-1. Advantages and limitations/challenges of diverse techniques used in glucose sensing 
Technique used in 
glucose sensing Advantages Limitations/Challenges 
HPLC 
1. It is easy to separate sugar mixtures and relatively free 
from interference. 2. It is accurate for quantification. 
 
1. It can be quite costly to use HPLC in glucose 
sensing (e.g. filtration of samples). 2. It is very time 
consuming in analyzing samples with HPLC. 3. The 
sensitivity of glucose sensing considerably depends 
on the types of column and HPLC used. 
Fluorescence 
spectroscopy 
1. It is a powerful technique for fast, mediatorless and 
noninvasive glucose sensing. [14] 2. It is highly sensitive for 
detection of low glucose concentrations in body fluid 
samples such as tears [11]. 
1. Active study is particularly needed in the area of 
exploring potential interferents, and designing sensor 
with wide detection range, high signal response, 
reproducibility and stability, extended lifetime, 
satisfactory accuracy and excellent biocompatibility. 
2. Besides, research efforts are also required to 
overcome the interference problems due to the 
“optical window” of the skin, to develop fluorescent 
transdermal glucose monitoring. [12, 14] 
IR spectroscopy 
1. It offers fast and reliable result. 2. The continuing 
improvements in hardware and software design make it a 
promising routine method during industrial process control 
[15].  
This technique is mainly used for quality control of 
glucose but not quantification [15].  





[16-19].  mM, which requires dilution of sample if its glucose 
concentration is above the detection range. 2. 
Biological samples may need filtration before 
detection. 3. Large assayed area is needed. 
NMR spectroscopy It is a great characterization tool for identification of metabolites of glucose metabolism [20].  This technique is not used for glucose quantification. 
Electrochemistry 
1. It is rapid, convenient and highly cost-effective compared 
to other techniques. 2. BGMDs are available commercially 
and new technique such as Alternative Site Testing instead of 
Fingerstick allows patients experience painless BGM. 
1. Accuracy of blood glucose reading can be delayed 
at alternate sites during times of rapidly changing 
blood glucose, making it more difficult to identify 
hyperglycemia or hypoglycemia. 2. Most 
electrochemical BGMDs based on invasive test. 3. 
Although minimally invasive and non-invasive 
glucose meters such as MiniMed Continuous Glucose 
Monitoring System and Cygnus GlucoWatch 
Biographer are commercially available, the results of 
these devices are not meant to be used as 
replacements for fingerstick-based tests, so patients 
must confirm these results with a standard glucose 
meter before corrective action is taken.  
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    Typically, an electrochemical glucose sensor employs a two- or three-
electrode system composed of working, reference and auxiliary (or counter) 
electrodes [5]. The sensing layer, containing active materials such as enzymes 
that react specifically with the glucose molecules, is coated on the working 
electrode. This configuration allows the working electrode potential to be 
measured against the reference electrode without compromising the stability 
of the reference electrode by passing current over it. The analyte diffuses into 
the sensor through a porous membrane to the working electrode, where it is 
oxidized or reduced, thereby generating the change of electric signal, which 
then passes through the external circuit comprising of amplifiers and other 
signal processing devices. The electrical signal is then converted to the analyte 
detection signal and displayed. 
    The most common electrochemical methods reported for glucose sensing 
are cyclic voltammetry (CV), amperometry, differential pulse voltammetry 
(DPV) and coulometry. CV is a popular technique to study the electrode 
process of an electrochemical reaction system. Based on the data plotted as 
current (I) and potential (E),  useful details such as the potential difference 
(ΔEp) between the anodic (Epa) and cathodic peak potential (Epc) at different 
scan rates, the relation between scan rates and redox peak currents, the ratio of 
anodic (Ipa) and cathodic peak current (Ipc) etc. can be obtained from CV curve. 
As a result, the redox potential of the analyte, type of the electrochemical 
reaction (e.g., reversible, irreversible or quasi-reversible), electrochemical 
reaction rate and other relative information are measured and obtained.  
Amperometry is another widely used electroanalytical technique which 
involves the application of a constant reducing or oxidizing potential to the 
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indicator (working) electrode and the subsequent measurement of the resulting 
steady-state current. Any analyte that can be oxidized or reduced is a 
candidate for amperometric detection. The simplest form of amperometric 
detection is single-potential amperometry in which the change of background 
current is able to be measured as an electroactive analyte is introduced, due to 
the occurrence of oxidation or reduction reaction of the analyte. As the analyte 
concentration varies, the measured current also changes. Therefore, the 
correlation between analyte concentration and current magnitude is obtained. 
The applied potential can be optimized to obtain a maximum response for the 
analyte of interest but a minimum response for interfering substances. 
    DPV is mostly used to study the redox properties of extremely small 
amounts of chemicals because the effect of the charging current can be 
minimized and hence high sensitivity can be achieved. Moreover, the faradic 
current is extracted so that electrode reactions are able to be analyzed more 
precisely. In contrast, if the redox properties of an analyte are known, DPV 
can be used for the determination of analyte concentration as the peak current 
is proportional to the concentration. Coulometry is an electrochemical 
technique that determines the amount of matter transformed during an 
electrolysis reaction by measuring the amount of electricity (in coulombs) 
consumed or produced [21].This technique has been applied commercially in 
Abbott Freestyle blood glucose meters because it can provide very linear 
glucose sensing signal under the constraints of a very tiny amount of blood 
sample (e.g., 300 nL), resulting in painless blood glucose monitoring [8]. 
1.1.2 Enzymatic versus non-enzymatic glucose detection 
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Generally, electrochemical glucose sensing strategies can be divided into 
two categories, enzymatic (i.e. the detection of glucose relying on the 
utilization of glucose-specific enzymes) and non-enzymatic (i.e. the 
determination of glucose without using enzymes). It is believed that enzymes 
have inherent limitations for the development of electrochemical glucose 
sensors as they could be thermally and chemically deformed, denatured, or 
inactivated, although they are satisfactory in terms of their relatively non-
toxicity and high specificity to the analyte, i.e. glucose. As a result, 
considerable research efforts have been made in the field of non-enzymatic 
glucose sensors over the past decade since it has been claimed that these 
glucose sensors are relatively inexpensive, more stable and sensitive compared 
to the enzymatic glucose biosensors [22-38]. And most of the non-enzymatic 
glucose sensors are developed based on the usage of various nanomaterials, 
such as CNTs [22-25], graphene [26-30] and metal or metal oxide NPs [31-38]. 
Unfortunately, the electrochemical sensing of glucose on nearly all the non-
enzymatic sensors needs to be performed in a basic solution phase (e.g., pH 
13.0) [22-29, 31-35], except for a few reports mentioning the accessibility of 
non-enzymatic glucose sensing in neutral medium [30, 36-38]. Hence, the 
requirement for basic medium inevitably restricts the clinical application of 
non-enzymatic glucose sensors as the pH value of human blood is about 
neutral. Additionally, most of the non-enzymatic glucose sensors apply 
relatively high overpotential (e.g., 0.5 to 0.7 V vs. Ag/AgCl) [22, 23, 26, 28, 
29, 31-34, 37, 38] where many common electroactively interfering substances 
can be oxidized, resulting in measurement error to the precise detection of 
glucose. Also, the non-enzymatic glucose sensing based on some specific 
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metal NPs such as PtNPs can suffer from surface fouling by chloride ion, and 
poor selectivity affected by creatinine, epinephrine, urea, ascorbic acid, and 
uric acid in blood [5]. Consequently, enzymatic glucose sensing is preferred in 
most of the commercially available blood glucose meters/monitoring systems 
[5]. 
1.1.2.1 Enzymes used in BGMDs 
Belonging to the family of oxido-reductases, glucose oxidase (GOx) and 
glucose dehydrogenase (GDH) are the most popular enzymes used in the 
commercial BGMDs for the highly specific glucose detection. Mostly isolated 
from Aspergillusniger, GOx is a dimeric protein of 160 kDa with each 
monomer composed of an identical polypeptide chain. A strongly bound redox 
cofactor, flavin adenine dinucleotide (FAD), is located at the reactive site of 
each subunit. It accepts electrons from glucose and is oxidized by oxidizing 
substances such as O2. During glucose oxidation, the oxidized form (GOx-
FAD) first reacts with glucose (Eq. (1)) followed by the oxidation of the 
reduced form (GOx-FADH2) and the production of hydrogen peroxide (H2O2) 
(Eq. (2)). Classically, H2O2 is oxidized at a catalytic Pt anode with the electron 
flow proportional to the number of blood glucose molecules (Eq. (3)). Stable 
GOx is commercially available at low cost and withstands greater extremes of 
operating conditions, i.e. less stringent conditions during the manufacturing 
process.  
Glucose + GOx-FAD → δ-Gluconolactone + GOx-FADH2                (1-1) 
GOx-FADH2 + O2 → GOx-FAD + H2O2                                             (1-2) 
H2O2 → 2H+ + O2 + 2e-                                                                          (1-3) 
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GDH belongs to the class of quinoproteins, which use 
pyrroloquinolinequinone (PQQ) as cofactor to convert glucose to 
gluconolactone [39]. GDH is also a dimeric enzyme composed of two 
identical protein monomers with each monomer binding a PQQ molecule and 
three calcium ions [40]. One of the three calcium ions activates the PQQ 
cofactor, whereas the other two are required for the functional dimerization of 
the GDH molecule. The oxidation mechanism of glucose by PQQ-dependent 
GDH is similar to that of GOx-FAD [41] (as shown in Eq (1-4) and (1-5)) 
with the exception that the reduced form (GDH-PQQH2) is not oxidized by O2 
[42, 43]. 
FAD + 2H+ +2e- → FADH2                                               (1-4) 
PQQ + 2H+ +2e- → PQQH2                                               (1-5) 
The apparent reduction potential of GOx-FAD at 25°C in the physiological 
medium at pH 7.2 is -0.048 V vs. standard hydrogen electrode (SHE) [44], 
whereas the reduction potential of GDH-PQQ is 10.5±4 mV vs. SHE at pH 
7.0 in the presence of excess Ca2+ [45]. The two enzymes also differ in their 
specificity for glucose [46, 47]. GOx-FAD is highly specific to glucose [48], 
although mannose can interfere even at low concentration [49]. GDH-PQQ 
exhibits similar catalytic efficiency to both glucose and non-glucose sugars 
such as maltose [50] which may cause potentially fatal errors in the glucose 
measurements in patients on medications that contain non-glucose sugars. 
Therefore, the US Food and Drug Administration agency’s public health 
notification in August, 2010 [51] recommended the public and healthcare 
facilities to avoid GDH-PQQ glucose test strips. 
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Nicotinamide adenine dinucleotide (NAD)- and FAD-dependent GDH have 
also been used in commercial BGM strips. Both GDH systems are quite 
specific for glucose apart from being independent of O2. Xylose may interfere 
with the glucose detection of GDH-NAD [52]. In addition, GDH-FAD may 
convert other non-glucose sugars such as maltose, mannose, galactose and 
lactose but only to a very small extent [53]. Although these non-glucose 
sugars are not present in diabetics or healthy persons, they may be present in 
individuals taking specific medication or having a rare disease condition. 
1.1.3 Mediator-based glucose detection 
As shown in Eq (1-1), after oxidizing glucose, GOx-FAD (i.e. the oxidation 
form of GOx) is reduced to GOx-FADH2 which needs to be re-oxidized for 
catalyzing the next circle of glucose oxidation. However, the direct electron 
transfer (DET) between the GOx active site and the surface of a conventional 
electrode is limited due to a thick protein layer, which surrounds the FAD 
redox center and results in an intrinsic barrier. Therefore, natural or artificial 
mediators are required to re-oxidize the GOx-FADH2. In the case of the GOx-
FAD system using O2 as an oxidizing agent (Eq (1-2)), the O2/H2O2 redox pair 
functions as a neutral mediator to transfer electrons (Eq (1-3)). However, the 
use of O2 may cause serious device limitation known as “oxygen deficit” [7], 
mainly attributed to the fluctuations in oxygen tension and the insufficient 
oxygen concentration compared to that of glucose in interstitial fluid, which 
may be several hundred folds greater [9]. This limitation introduces variability 
in the sensor response and decreases the upper glucose detection limit. 
Moreover, the detection of glucose based on H2O2 oxidation requires high 
overpotential (e.g., +0.6 V vs. SCE at Pt anode, Eq (1-3)), where many co-
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existing interfering substances can also react at the sensing electrode, inducing 
errors in glucose measurements. On the other hand, if an artificial mediator is 
used, when GOx-FAD oxidizes glucose to gluconolactone, electrons are 
transferred from glucose to the oxidized form of the mediator (i.e. Mox) 
thereby reducing it (Eq (1-6)). The reduced mediator (i.e. Mred) is then re-
oxidized by the electrode for electrochemical detection of glucose (Eq (1-7)). 
GOx-FADH2 + 2Mox → GOx-FAD + 2Mred + 2H+                  (1-6) 
2Mred → 2Mox +2e-                                                                    (1-7) 
    In the case of the enzyme using an artificial mediator to facilitate the 
electron transfer between GOx and electrode surface, the mediator should be 
able to compete with O2 and to react rapidly with the enzyme cofactor at a low 
redox potential. Unfortunately, the reaction between O2 and GOx-FADH2 may 
still occur in the presence of a rapid mediator, especially when O2 is freely 
diffusing [4]. Besides, it has been known that even at a low redox potential, 
some interfering substances yet tend to interact with the mediator, thereby 
causing faults in glucose measurements [4]. For an implantable BGMD, the 
disadvantage of using artificial mediator could be the potential diffusion of 
mediator out of the sensing layer which may also considerably affect the 
accuracy of glucose monitoring [6]. Apart from this, the leached mediator may 
be harmful to human body owing to its intrinsic toxicity. In summary, due to 
the limitations of using artificial mediator in glucose monitoring system 
mentioned above, a mediatorless glucose sensing strategy that can detect 
glucose at a low applied potential will be an ideal solution to avoid the 
interference induced by mediator and interfering substances, and to preserve 
the high selectivity of enzymatic glucose sensing. 
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1.2 Mediatorless glucose sensing strategies: literature review 
    During the past decade, mediatorless glucose biosensors have been 
extensively developed based on the utilization of various electrode materials. 
The following sub-sections mainly review the development of mediatorless 
glucose biosensors especially those which have been reported recently; the 
mechanisms of glucose sensing based on these biosensors are also discussed.  
1.2.1 Nanomaterial-based glucose biosensors 
    The rapid rise of research focusing on nanomaterial fabrication intensively 
stimulates the development of mediatorless glucose biosensors based on the 
utilization of various nanomaterials. Prior to the pioneering work done by Loh 
et al. [54] in 2004, in which CNTs were first used for preparing mediatorless 
electrochemical glucose biosensor, metal/metal oxide NPs or the composites 
synthesized based on these NPs were used as the primary electrode materials 
for the fabrication of mediatorless glucose biosensors. Over 1,600 research 
papers regarding CNT-based mediatorless glucose biosensors have been 
published so far. Interestingly, the groundbreaking contribution from Geim 
and Novoselov on the experiment regarding graphene in 2007 [55] seems shift 
researchers’ attention from CNTs to this newly introduced nanomaterial for 
developing mediatorless glucose biosensors. In the following contents, the 
development of CNT- and graphene-based mediatorless glucose biosensors is 
mainly reviewed and the development of glucose biosensors based on other 
types of nanomaterials is also discussed.  
1.2.1.1 CNT-based glucose biosensors 
As hollow cylindrical tubes made up of carbon with extremely high length-
to-diameter ratio, CNTs have one to several concentric graphite layers capped 
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by fullerenic hemispheres [56]. Apart from their highly thermal conductive, 
mechanically strong and chemically stable nature, the high surface-to-volume 
ratio of CNTs is also an advantage for the functionalization of NPs and 
immobilization of enzymes such as GOx [56, 57]. Undoubtedly, CNTs have 
opened new avenue for the development of nanomaterial-based mediatorless 
glucose biosensors. 
In 2004, Loh et al. reported an amperometric glucose biosensor was 
constructed by covalently immobilizing GOx on a 3,3’-diaminobenzidine 
electropolymerized multi-walled carbon nanotube (MWCNT) electrode 
surface [54]. In this work, the oxidation of H2O2 could be performed at 0.3 V 
vs. Ag/AgCl with negligible interference signals from ascorbic acid and uric 
acid. Thereafter, Luong and coworkers published the solubilization of 
MWCNTs in the mixture of 3-aminopropyltriethoxysilane (APTES), [58] 
Nafion and ethonal and the application of the MWCNT suspension in 
fabricating glucose biosensor which could sense glucose at -0.45 V vs. 
Ag/AgCl. For the construction of glucose biosensors, CNTs were also used 
with polymers [59, 60] or decorated with metal NPs (such as Ag [61], Au [62], 
Pt [63], Cu [64], etc.), metal oxide NPs (such as ZnO [65, 66], Fe3O4 [67, 68], 
TiO2 [69]) and other nanomaterials [70-72].  
Very recently, Chen and coworkers developed an amperometric glucose 
biosensor by MWCNTs decorated with platinum palladium dimetal NPs with 
high sensitivity of 112 µA mM−1 cm−2 for glucose sensing [73]. Besides 
detecting commercial glucose, they also measured varying blood glucose 
concentrations in serum samples by using the developed biosensor. The blood 
glucose result was also compared with that obtained by YSI 2300 STAT Plus 
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Glucose Analyzer. This work provides a comprehensive guide to the study of 
the analytical performance of a glucose biosensor. However, since the 
detection of glucose is based on the oxidation of H2O2, the applied potential of 
the biosensor is relatively high (i.e. 0.6 V vs. SCE), leading to enhanced 
possibility of being interfered by reducible substances. Additionally, this study 
provides very limited information about the anti-interference performance of 
the biosensor since only a few interfering substances were tested. Another 
novel glucose biosensor by immobilizing GOx on MWCNTs-coated 
electrospun gold fibers has been reported by Jose et al. [74]. It is noteworthy 
that the biosensor could linearly detect up to 30 mM glucose, which is the 
upper limit of the pathophysiological blood glucose range [5]. Nevertheless, 
the study of anti-interference behavior of the biosensor is ignored by this work. 
The direct electrochemical sensing of glucose based on the immobilization of 
GOx on functionalized MWCNTs was also reported by Tu et al. [75]. The 
technique for immobilization of GOx was quite interesting, which was by the 
affinity interaction of the histidine and cysteine moieties on the surface of 
GOx to the Co(II) ions of the metal chelates functionalizing on MWCNTs. 
However, the preparation time of this glucose biosensor was very lengthy 
(i.e. >24 h). Also, the biosensor could detect up to only 3.7 mM glucose which 
is obviously insufficient for glucose monitoring in diabetes. Besides 
MWCNTs, single-walled carbon nanotubes (SWCNTs) have also been applied 
in the development of mediatorless glucose biosensors. Dung and coworkers 
reported a glucose biosensor based on the titanium oxide-decorated SWCNTs 
[76]. The glucose biosensor showed maximum response to the reduction of 
H2O2 at -0.25 V vs. SCE. Owing to the relatively low potential, the 
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interference of ascorbic acid and uric acid was minimized. Yet this biosensor 
again failed to detect high glucose levels (note that the reported linear range 
was up to 1.4 mM) and its response time to glucose was not fast enough (i.e. 9 
sec) to meet the requirement of developing a modern BGMD [5]. 
1.2.1.2 Graphene-based glucose biosensors 
Compared to CNTs, graphene is a relatively new member of the family of 
carbon-based nanomaterials. Its structure is one-atom-thick planar sheets of 
sp2-bonded carbon atoms densely packed in a honeycomb crystal lattice [55]. 
Graphene is receiving increasing attention in the field of biosensors due to its 
unique physicochemical properties such as high surface area [77], excellent 
electric conductivity [55], strong mechanical strength, biocompatibility, ease 
of functionalization and mass production [78]. This two-dimensional material 
has shown great promise as electrode material for the immobilization of GOx 
and improvement of DET between GOx and electrode surface [79-81]. 
Therefore, more and more research efforts have been made in the development 
of graphene-based mediatorless electrochemical glucose biosensors. 
The novel application of utilizing graphene for constructing mediatorless 
glucose biosensor was published by Shan et al. in 2009 [80], in which the GOx 
was immobilized on a polyvinylpyrrolidone-
protectedgraphene/polyethylenimine-functionalized ionic liquid (IL) modified 
glassy carbon electrode (GCE). This biosensor was able to detect glucose with 
a linear range from 2-14 mM at -0.49 V vs. Ag/AgCl. Zhou et al. thereafter 
reported another graphene-based glucose biosensor capable of sensing up to 
10 mM glucose at -0.2 V vs. Ag/AgCl [82]. In the same year, Lin’s group also 
published their work of employing graphene together with other electrode 
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materials such as PtNPs [83] and chitosan [79, 83] for the development of 
glucose biosensors. After 2009, researchers also attempted to decorate 
graphene with porphyrin compound [84], multi-metal NPs [85] or apply 
graphene and GOx onto a screen-printed electrode [30]. All of these studies 
have extended the application of graphene in the field of mediatorless glucose 
biosensors. 
Very recently, Qiu and collaborators reported the controllable deposition of 
PtNPs ensemble on apolyaniline/graphene hybrid [86] for the immobilization 
of GOx. The relation between PtNPs loading and glucose sensing signal was 
also investigated by the researchers. The biosensor exhibited a high sensitivity 
toward glucose (i.e. 131.7 µA mM-1 cm-2). Yet the applied potential of this 
biosensor was relatively high (e.g., 0.6 V vs. Ag/AgCl) and the details about 
the anti-interference behavior of the biosensor was lacking in this study. 
Except for PtNPs, other metal NPs have also been used in constructing 
graphene-based glucose biosensors. Zhang et al. [87] and Luo et al. [88] 
reported the preparation of glucose biosensors based on AgNPs-graphene 
composites. The one-pot synthesis of AgNPs-graphene composites reported by 
Zhang et al. [87] was quite convenient and it may provide a general guideline 
for the one-pot synthesis of other metal NPs-graphene composites applicable 
in glucose biosensors. Unfortunately, the experimental result regarding the 
effect of interfering substances on glucose sensing had not been mentioned in 
this work. The synthesis of AgNPs-graphene composites reported by Luo et 
al.[88] seemed more complicated than the approach used by Zhang and 
coworkers [87]. Additionally, the glucose biosensor proposed by Luo et al. 
exhibited much lower glucose linearity (i.e. 0.032-1.89 mM) than that reported 
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by Zhang et al. (i.e. 2-10 mM). The composites of graphene and other material 
have also been reported. Guo and coworkers synthesized the graphene-metal 
coordination polymer composite nanosheet that performed superior 
conductivity and electrocatalytic activity for H2O2 reduction than bare 
graphene [89]. The prepared glucose biosensor was highly sensitive and 
capable of providing a linear response range between 50 nM and 1 mM 
glucose with an extremely low detection limit of 5 nM. A relatively wide 
range of interfering substances had been tested, compared to most of the 
published studies regarding graphene-based glucose biosensors. However, this 
glucose biosensor may not be suitable for the application in sensing blood 
glucose in diabetes as its linearity is much lower than the pathophysiological 
glucose range. Noticeably, in the contribution of Gu and coworkers [90], the 
layer-by-layer self-assembling of amine-terminated IL, and sulfonic acid 
functionalized graphene has been obtained. The assembled graphene layers 
were then modified with GOx for the fabrication of glucose biosensor. This 
study is highly commendable for providing important information on the in 
vivo application of the proposed biosensor. As mentioned in the paper [90], 
the biosensor was used to sense glucose level in the striatum of rats as they 
received intraperitoneal injection of certain amount of insulin (e.g., 30 µL). 
Thereafter, an apparent decline in the extracellular glucose level was observed 
within 30 min. Nevertheless, the low linearity of the sensor seemed to restrict 
its application in blood glucose monitoring. Moreover, the preparation time of 
fabricating this glucose biosensor was comparatively lengthy (i.e. >24 h) 
which could increase the manufacturing cost.  
1.2.1.3 Glucose biosensors based on other types of nanomaterials 
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Besides CNTs and graphene, other formats of carbon-based nanomaterials 
have also been applied in the fabrication of mediatorless glucose biosensors. 
For instance, platelet graphite nanofibers possessing electroactive edge sites 
was used with polysulfone for the construction of a glucose biosensor that 
could detect low level of glucose at 0.15 V vs. Ag/AgCl [91]. The effect of 
different loading of the platelet graphite nanofibers on the glucose sensing 
signals was investigated in the same study. However, the experimental details 
regarding the interfering substances were lacking. The thin-walled graphitic 
nanocages with well-developed graphitic structure, large specific surface area 
and pronounced mesoporosity was also employed as a sensing interface for 
amperometric glucose sensing; and up to the medium level of glucose (e.g., 
6.2 mM) was detectable [92] by the graphitic nanocage-glucose biosensor. It is 
noteworthy that the effect of several common interfering substances (such as 
ascorbic acid, uric acid, dopamine, and acetaminophen) on glucose sensing 
was performed in human serum that contained glucose. This experiment 
demonstrated the possible application of the proposed glucose biosensor in 
real sample testing.  
Intensive research efforts have also been made in the fabrication of 
mediatorless glucose biosensors by using diverse metal/metal oxide NPs or 
composites synthesized based on metal/metal oxide NPs. The most common 
metal/metal oxide NPs include AuNPs [93-95], PtNPs [96], ZnO [97-99], 
NiO2 [100] etc. These metal/metal oxide NPs can be used together with 
biopolymers such as chitosan [93, 94], conducting polymers such as 
polypyrrole [95] and polyaniline [101, 102], inorganic materials [96] 
(including CNTs and graphene), ILs [103] and other materials. For example, 
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the amperometric glucose biosensor fabricated by layer-by-layer (LbL) 
assembly of multilayer films of chitosan, AuNPs and GOx on a Pt electrode 
was reported by Wu et al. [94] It is noteworthy that the glucose biosensor 
could determine varying concentrations of glucose (1-16 mM) that were added 
into human serum sample and the recovery values were between 98.8% to 
106%. Yet the detection was performed under a relatively high potential (e.g., 
0.6 V vs. Ag/AgCl) and the fabrication procedures were tedious and 
complicated. Senel and coworkers reported a glucose biosensor constructed by 
the immobilization of GOx on poly(pyrrolepropylic acid)/AuNPs composite 
[95]. The biosensor was able to detect up to 18 mM glucose and its response 
time to glucose was very short (i.e. ~2 sec). However, the biosensor still 
requires a high applied potential (e.g., 0.6 V vs. Ag/AgCl) for the 
determination of glucose. Besides AuNPs, PtNPs have also been employed by 
researchers for the development of glucose biosensor. Zeng et al. reported the 
construction of a glucose biosensor based on the decoration of chitosan, IL 
and GOx on the surface of an Au electrode that was electrochemically 
deposited with AuNPs [103]. The electrode was able to detect 3 µM to 9 mM 
glucose at the applied potential of 0.6V vs. Ag/AgCl. Yu and collaborators 
deposited PtNPs on the mesoporous carbon material (CMK-3) for the 
immobilization of GOx and casted the enzyme-PtNPs-CMK-3 mixture on a 
GCE for glucose sensing. Although it could detect up to 12.2 mM glucose, the 
applied potential of this biosensor was not decreased compared to the LbL 
AuNPs [94], poly(pyrrolepropylic acid)/AuNPs [95] and chitosan-IL-AuNPs 
[103] glucose biosensors. Additionally, metal oxide such as ZnO has also been 
applied as electrode material to fabricate a glucose biosensor. Dai et al. [98] 
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synthesized a tetragonal pyramid-shaped porous ZnO (TPSP-ZnO) 
nanostructure with large surface area and superior biocompatibility for the 
immobilization of GOx. The DET between GOx and the electrode surface was 
observed on the GOx-TPSP-ZnO modified GCE. At an applied potential -0.5 
V vs. SCE, the electrode was able to detect glucose in PBS and human serum 
sample. In another report, hollow sphere-nanostructured conducting 
polymer/NiO composite was used to facilitate the DET between GOx and 
electrode surface [100]. It is highly recommendable that this paper discussed 
the mechanism of glucose oxidation catalyzed by the enzyme-polymer-NiO 
composite in the presence and absence of oxygen in details.   
1.2.2 Glucose biosensors developed without using nanomaterials 
Despite tremendous reports toward glucose biosensors designed based on 
various nanomaterials, mediatorless glucose detection without using 
nanomaterial has also been studied by many researchers. In such cases, the 
enzyme is usually entrapped in polymer, liposome, sol-gel or hydro-gel, by 
which it can be immobilized on the electrode surface. Due to their remarkable 
optical, electrochemical, and conducting properties [104], porous organic 
semiconducting polymers have attracted considerable attention in the 
development of electrochemical glucose biosensors. It was reported that lipid 
bilayers could be a suitable diffusion limiting membrane as it is much more 
permeable to O2 than glucose [105]. Therefore electrodes modified with GOx 
entrapped in liposomes seem to be promising tools for electrochemical glucose 
sensing [106, 107]. In addition, sol-gel film could also be used to entrap GOx 
owing to the inherent low temperature process of the sol-gel technology [108]. 
The chemical inertness, physical rigidity, negligible swelling in aqueous 
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solution and tunable porosity of sol-gel silica matrix are also attractive 
features to the construction of electrochemical glucose biosensor [108]. 
Hydrogel is known as a biocompatible material because of its high water 
content [109]. It allows the in vivo monitoring of analytes (such as glucose and 
cholesterol) so it becomes a very popular in fabricating implantable devices. 
Mesostructured polyaniline prepared by the self-assembly of anionic 
surfactant and non-ionic polymeric surfactant was used as electrode material 
for GOx immobilization [110]. The electrode was able to sense up to 45 mM 
H2O2 at 0.6 V vs. Ag/AgCl. Thereafter the electrode was used to detect up to 
20 mM glucose based on the oxidation of H2O2 (Eq (1-3)). A simple glucose 
biosensor with micromolar sensitivity was developed by utilizing a poly(3,4-
ethyelenedioxythiphene) poly(styrene sulfonate) based electrochemical 
transistor in which all the electrodes and the channel were made with the same 
polymer [111]. The biosensor was able to detect glucose from 1 µM to 10 mM 
and it was also used to detect glucose in human saliva (8 to 210 µM) in the 
absence of redox mediator. GOx was also demonstrated its covalent 
immobilization on an electrochemically prepared co-polymer composed of 
amidoamine and pyrroledendrimers [112]. The biosensor could detect up to 
about 5 mM at the applied potential of 0.7 V vs. Ag/AgCl without being 
affected by common interferents such as ascorbic acid, uric acid and 
acetaminophen. Memoli et al. reported the encapsulation of GOx in liposomes 
and the prepared glucose biosensor was able to detect up to 20 mM [113]. 
Nevertheless, the sensor stability and effect of interfering substances were not 
mentioned in this report. Choi and collaborators constructed an amperometric 
glucose biosensor based on the sol-gel-derived TiO2/Nafion composite films 
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which could determine up to 7 mM glucose [108]. This biosensor was also 
able to reserve 80% of its initial activity for about 4 months while it was 
stored in 50 mM phosphate buffer solution (PBS) due to the biocompatible 
matrix employed. Yang et al. designed an implantable electrochemical glucose 
biosensor by using zwitterionic hydrogels based on poly(carboxybetaine) 
methacrylate to protect the biosensor from biofouling in complex media [114]. 
It is noteworthy that the glucose sensing signal of this biosensor was not 
decreasing after exposure to blood samples for over 12 days. 
1.3 The mechanisms of glucose detection by mediatorless glucose 
biosensors 
Basically, three types of mechanisms of glucose detection are available for 
mediatorless glucose biosensors. The first mechanism is based on the 
electrochemical oxidation of H2O2 (Eq (1-6)), the by-product of enzyme 
catalyzed glucose oxidation (Eq (1-1) and (1-2)). With the increase of glucose 
concentration, the anodic current of H2O2 oxidation increases accordingly and 
thus the correlation between glucose concentrations and current values is 
established. Because the high overpotential of H2O2 oxidation may induce 
interfering signals caused by the co-oxidation of reducible substances (such as 
ascorbic acid, uric acid, dopamine, acetaminophen, etc.), many researchers 
attempted to search for novel electrode materials capable of lowering the 
overpotential of H2O2 oxidation. However, most of the reported glucose 
detections based on this mechanism still require relatively high overpotential 
for the oxidation of H2O2. So far, only a few papers have reported the 
successful reduction of the overpotential for the electrochemical oxidation 
reaction of H2O2 [54, 60, 63, 68, 91, 93].  
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The second mechanism is based on the electrochemical reduction of H2O2 
(Eq (1-8)). The reduction of H2O2 occurs at negative potentials so that the co-
oxidation of interfering substances is possible to be prevented. Similarly, with 
the increase of glucose concentration, the cathodic current of H2O2 reduction 
increases accordingly and thus the calibration between glucose concentrations 
and current values is accessible. Electrode materials exhibiting catalytic 
property toward the reduction of H2O2 have been employed to fabricate 
glucose biosensors [64, 76, 82, 84, 87-89]. Alternatively, hydrogen peroxidase 
that processes excellent catalysis toward H2O2 reduction can be used together 
with GOx to construct a so called bienzymatic glucose biosensor [115-121]. 
H2O2 + 2e- +2H+ → 2H2O                                           (1-8) 
Last but not least, the reduction of O2 by the enzyme GOx (FADH2-GOx) 
can also be utilized to analyze glucose concentrations [75, 79, 80, 92, 98, 100]. 
This mechanism is based on Eq (1-2).  In case of applying CV to monitor this 
process, decrease of cathodic peak current can be observed according to the 
increase in glucose. The reduction wave actually corresponds to the FADH2-
GOx catalysed reduction of O2. More specifically, as the O2 is consumed by 
the reaction between glucose and GOx (Eq (1-2)), the concentration of O2 near 
the electrode surface is reduced, resulting in the decline in reduction current 
with an increase in glucose concentration. Therefore, the proportionate 
decrease of reduction current with the increase in glucose concentration can be 
employed to determine the glucose levels. Although the detection of higher 
levels of glucose will be restricted owing to the limited concentration of 
dissolved O2, a thin layer of limiting membrane may effectively help to 
prevent the enzyme from reacting with the excessive glucose molecules and 
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hence the dissolved O2 concentration could be sufficient for detecting higher 
levels of glucose. In addition, the use of air- or oxygen-saturated electrolyte 
should help to avoid the fluctuation in O2 pressure. 
Detection of glucose based on the DET of GOx is still a huge challenge 
since the redox center of the enzyme (i.e. FAD/FADH2) is deeply embedded 
by a thick layer of amino acids. Although glucose accesses this redox center 
by means of diffusion and penetration of the three dimensional molecular 
network [122], which leads to the occurrence of glucose oxidation catalyzed 
by GOx-FAD (Eq (1-1)), the direct re-oxidation of GOx-FADH2 by electrode 
(Eq (1-8)) is very difficult on a planar electrode. The development of nano and 
porous materials has provided large enhancement in the electrode surface and 
dynamics [123-125]. Nanomaterials such as CNTs could facilitate the DET of 
enzyme probably by shortening the electron tunneling distance between 
enzyme and electrode surface [100]. Mesoporous materials are also very 
popular as they are capable of entrapping and encompassing the enzymes so 
that the DET between enzyme and electrode surface could be achieved [124, 
125]. However, even in such cases, the interfering effect of dissolved oxygen 
could still compete with the electrode and involve in the reoxidation of 
FADH2-GOx [122]. This might be the reason that the detection of glucose 
based on the DET between enzyme and electrode surface has seldom been 
reported by researchers [100]. 
GOx-FADH2 - 2e- → GOx-FAD + 2H+                                     (1-8) 
1.4 Objectives and significance of the study 
1.4.1 Research gaps of the study 
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Based on the literature review, the research gaps of the current study on the 
development of mediatorless glucose sensing strategies are summarized as 
below: 
• Many of the published mediatorless glucose sensing strategies have 
employed lengthy and complicated procedures which are costly and 
unfavorable to mass production. Moreover, most of the reported strategies 
failed to detect the diabetic pathophysiological range, resulting in their 
incapability for real sample analysis. 
• The sensor performances of the proposed glucose biosensors have not been 
systematically studied by most of the published reports. For instance, only 
the effect of a few common interferents on glucose sensing was provided, 
but the detailed information of several drug metabolites and non-glucose 
sugars is lacking. Besides, the effect of biofouling on glucose sensing has 
seldom been mentioned in most of the studies. 
• Most of the prepared glucose biosensors have not been used to detect 
varying blood glucose concentrations in real or standardized blood 
samples. 
1.4.2 Aim and objectives of the study 
    This study aimed to develop mediatorless electrochemical glucose sensing 
strategies for the highly precise detection of glucose in the diabetic 
pathophysiological range of 1-30 mM; the proposed strategies would be free 
from interference caused by most of the interfering substances coexisting in 
human blood. The specific objectives of this research were to: 
• develop rapid, robust and cost-effective methods for the preparation of 
enzymatic mediatorless glucose biosensors capable of detecting the entire 
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diabetic pathophysiological range, based on the utilization of various 
electrode materials (e.g., MWCNTs, graphene, etc.) and the optimization 
of important parameters during the process of biosensor development. 
• systematically investigate the sensor performance in terms of anti-
interference (based on the electrochemical response to several endogenous 
substances, drug metabolites and non-glucose sugars) and anti-biofouling 
capacity, production reproducibility, sensor stability under different 
storage conditions, etc.  
• investigate the availability of proposed glucose biosensors to detect 
varying blood glucose concentrations in Sugar-Chex whole blood glucose 
linearity standards (standardized blood samples) obtained from Streck, Inc. 
1.4.3 Significance and scope of the study 
    The methods of preparing glucose biosensor proposed by this study may 
contribute practical benefits to the construction of other mediatorless 
electrochemical biosensor formats. Moreover, this study could be of 
significant economic importance since the existing market of BGMD is 
unprecedentedly substantial, as mentioned previously. Last but not least, the 
systematic investigation of sensor performance in this study should provide 
valuable guidelines for the development of non-invasive glucose sensor, which 
is an ideal technique to monitor blood glucose levels without accessing blood, 
preventing the forming of wounds on diabetics’ skin that are difficult to heal 
due to microangiopathy. 
Due to the restriction of accessing patient blood samples in Singapore, 
Sugar-Chex whole blood glucose linearity standards purchased from Streck 
Inc. (USA) are used as substitute in this thesis. Additionally, since the 
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preparation of screen printed electrodes requires special instruments which are 
beyond the current experimental conditions, the biosensor fabrication process 
and electrochemical experiments of this thesis are performed on normal disc 
electrodes. 
1.4.4 Overview of the thesis 
    The experimental details of this thesis will be provided in Chapter 2. The 
development of mediatorless electrochemical glucose biosensors based on 
MWCNTs, graphene and other electrode materials will be discussed in 




















Chapter 2 Experimental 
2.1 Electrochemical analysis 
    All electrochemical measurements were performed at room temperature 
(RT, 25 ± 2 °C) on the CHI 660A electrochemical workstation (CH 
Instruments, Austin, TX) with a three-electrode system: working electrode, 
silver/silver chloride (Ag/AgCl in 3.0 M KCl) reference electrode and Pt wire 
counter electrode. The working electrodes used throughout the present 
research included various developed glucose biosensor and control electrodes. 
The electrochemical system setup is shown in Fig. 2-1. The electrolyte used in 
various electrochemical measurements will be specified in corresponding 
sections. All potentials were referred to Ag/AgCl. Unless specified, the 
electrochemical measurements were performed in the presence of oxygen 
dissolved in reaction mixture in ambient air temperature. For electrochemical 
tests carried out in the nitrogen-saturated buffer, the electrolyte was bubbled 
with pure nitrogen for 10 min just before the experiments and the nitrogen 
environment was maintained during electrochemical detection. 
2.1.1 Cyclic voltammetry 
    CV was used for the electrochemical characterization of the developed 
glucose biosensors in the presence or absence of oxygen; 50 mM PBS (pH 7.4) 
or varying concentrations of glucose solution (prepared in 50 mM PBS) were 
used as electrolytes. This technique was also employed for the determination 
of the effective surface area of functionalized GCE and the experiments were 
carried out in 5 mM K3Fe(CN)6 (issolved in 0.5 M KCl). CV measurements 




Fig. 2-1. Schematic diagram of the electrochemical system used for the 
electroanalytical experiments in this research. WE: working electrode; RE: 
reference electrode; CE: counter electrode. The electrodes and the gas tube 
were inserted through holes in the cell cover. 
 
2.1.2 Amperometry 
    In this study, amperometric measurements were performed at -0.45 V.  50 
mM PBS was used as the electrolyte for all measurements.  
2.1.2.1 Detection of glucose and blood glucose 
    Glucose stock solution (1 M) was stored overnight at RT for complete 
mutarotation. The detection of varying concentrations of glucose was done by 
injecting different volumes of glucose stock solution into stirred PBS to form 
2 mL of 0.5, 1, 2, 4, 8, 16, 32 or 48 mM glucose. All the concentrations were 
detected individually in triplicate. The determination of blood glucose was 
obtained by injecting 400 µL of Sugar-Chex blood glucose linearity standards 
(providing different glucose concentrations) into 2.8 mL of stirred PBS. The 
results obtained were then multiplied by the dilution factor. A semi-
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logarithmic plot was used for treating glucose sensing data as it led to a 
uniform spacing on the X-axis without impacting the nature of assays. It has 
been widely used in many biosensing applications such as SPR [126], 
immunossays [127], electrochemical sensing [128, 129], and point of care 
devices, etc. [130]. 
2.1.2.2 Effect of interfering substances on glucose detection 
    The effect of non-glucose sugars, biological substances and drug 
metabolites on glucose detection was performed on each biosensor. All non-
glucose sugars (i.e. galatose, lactate, lactose, maltose and xylose), ascorbic 
acid, dopamine, creatinine and acetaminophen were dissolved in 50 mM PBS. 
Uric acid and bilirubin were prepared in 10 mM NaOH; tetracycline was 
prepared in 1 M HCl; ibuprofen, salicylate and tolbutamide were dissolved in 
absolute ethanol; and, tolazamide was dissolved in acetone. The stock 
solutions of all interfering substances were prepared freshly just before testing. 
The effect of interference was determined by the measurement of the current 
signals of such interferents in the presence of a medium level of Streck blood 
glucose (6.6 or 6.8 mM, depending on different batch of product). When 
plotting the experimental data regarding the effect of interfering substances, 
the sensing signal generated from blood glucose was deducted, hence the 
signal shown on figures for each interfering substance was considered the 
detection error generated purely by the interfering substance. 
2.1.2.3 Production reproducibility of glucose sensing strategies 
    Each of the developed strategies was used for preparing 25 GOx-bound 
GCEs. The production reproducibility was then determined by the 
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electrochemical detection of particular concentration of glucose (in triplicate) 
on each electrode. 
2.1.2.4 Stability of glucose biosensors stored under various conditions 
    Four different storage conditions were applied to the developed glucose 
biosensors: storage in 50 mM PBS at 4 °C and at RT, and storage in dry state 
(without PBS) at 4 °C and at RT. The glucose biosensors were employed for 
detecting particular concentration of glucose ten times each day from the time 
they were freshly prepared (corresponding to 100% signal strength). 
2.1.2.5 Continuous glucose monitoring 
    The developed glucose biosensors were used for continuous glucose 
monitoring, where a particular concentration of glucose was detected 150 
times using the same electrode. 
2.1.2.6 Effect of biofouling on glucose detection 
    The freshly prepared glucose biosensor was used to detect 4 mM glucose 
first. Then the same electrode was rinse thoroughly and used to detect 6.6 mM 
Streck glucose. Thereafter this electrode was rinse thoroughly and used to 
detect 4 mM glucose. This process was repeated for several times. 
    Alternatively, the developed glucose biosensor was stored overnight at RT 
dipped in Streck Sugar-Chex blood glucose linearity standard (1 mM). The 
biofouling was determined by taking the current signal of the glucose 
biosensor for detecting a particular concentration of glucose immediately after 
preparing the biosensor and every day after storing in Streck blood glucose 
standard for 5-7 days. 
2.2 Bicinchoninic acid protein assay 
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    The bicinchoninic acid (BCA) protein assay [131] is widely used for 
determination of protein concentrations ranging from 25 to 2000 µg mL-1. As 
a water-soluble sodium salt, BCA exhibits high sensitivity and specificity for 
Cu1+. Similar to the Biuret reaction [132], the presence of protein in an 
alkaline medium reduces Cu2+ to Cu1+. Consequently, a purple-colored 
reaction product is formed by the chelation of two molecules of BCA with 
each Cu1+, which exhibits a strong absorbance at 562 nm. The total protein 
concentration is reflected by the sample color change from green to purple in 
proportion to a given protein concentration. The color formation caused by the 
reaction of protein with BCA is dependent on its number of peptide bonds, its 
macro molecular structure, and the availability of four amino acids (cysteine, 
cystine, tryptophan, and tyrosine) in the protein [133]. The amino acid 
sequence, pI, and the presence of certain side chains or prosthetic groups can 
also affect the color formation significantly. The extent of the color formation 
is determined by more than the sum of individual color-forming functional 
groups [133]. 
To study the robustness of immobilized enzyme on the electrode surface, 
the developed glucose biosensors and the control electrode were immersed in 
200 µL of BCA working reagent inside the micro centrifuge tubes and 
incubated at 80 °C for 15 min. The colored products formed (180 µL each) 
were then transferred to the 96-well microtiter plate, whose absorbance was 
read at 562 nm by a Tecan Infinite M200 Pro micro plate reader. The 
absorbance of control electrode was subtracted from that of the developed 
glucose biosensors to determine the total concentration of GOx bound to the 




Fig. 2-2. The formation of purple complex with BCA and cuprous ion. 
2.3 Helium ion microscopy 
    Scanning helium ion microscope (HIM) is a new imaging technology based 
on a scanning helium ion beam [134]. Because of the high source brightness 
and the short De Broglie wavelength of helium ions, which is inversely 
proportional to their momentum, HIM can provide qualitative data not 
achievable with conventional microscopes (using photons or electrons as the 
emitting source). Moreover, as the helium ion beam interacts with the sample, 
it does not undergo a large excitation volume; therefore HIM can produce 
sharp images on a wide range of materials. Also, little sample damage is found 
due to relatively light mass of the helium ion. HIM was used for 
characterization of the surface feature of the GOx-bound electrodes. 
2.4 Scanning electron microscopy 
Scanning electron microscopy (SEM) is one of the most extensively used 
techniques for obtaining the topography and other useful information on the 
sample surface where a high energy beam of electrons scans in a raster scan 
pattern. In this research, the surface characterization of  nanomaterial 
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functionalized glassy carbon substrate was done by imaging the surface using 
JEOL SEM at 15 kV (JSM-6010LV, Japan). 
2.5 Energy-dispersive X-ray spectroscopy 
    Energy-dispersive X-ray spectroscopy (EDX) is an analytical technique 
used for the elemental analysis or chemical characterization of a sample, 
which relies on the investigation of an interaction of some source of X-ray 
excitation and a sample. In this study, the deposition of specific materials on 
the surface of the GCE in each step was confirmed by the SEM-EDX analysis. 
The SEM-EDX analysis was performed on a Hitachi S 2600N SEM (Hitachi 
Scientific Instruments, Tokyo, Japan) equipped with a micro analysis detector 
for EDX (Inca x-act, Oxford Analytical Instruments, Abington, UK). EDX 
spectra were collected at 30°angle, 20 kV accelerating voltage and 20 mm 
working distance. EDX results were analyzed using incorporated Inca, Point 
and Analyze software. 
2.6 Raman spectroscopy 
    Raman spectroscopy is a spectroscopic technique used for the study of 
vibrational, rotational and other low-frequency modes in a system. It is based 
on the inelastic scattering (Raman scattering) of monochromatic light from a 
laser in the visible, near infrared or near ultraviolet range. The interaction 
between the laser light and molecular vibrations, phonons or other excitations 
in the system leads to shifting up or down of the energy of the laser photons. 
The shift in energy gives information about the vibrational modes in the 
system. The Raman spectra of the nanomaterials used in this research were 
recorded using a Renishaw micro-Raman system coupled to an air-cooled 
photomultiplier tube using the 514.5 nm line of Ar+-ion laser.  
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2.7 Infrared spectroscopy 
    As another spectroscopic technique, infrared spectroscopy deals with the 
infrared region of the electromagnetic spectrum, i.e. light with a longer 
wavelength and lower frequency than visible light. It is mostly based on 
absorption spectroscopy and used for identification and study of chemicals. IR 
spectroscopy provides similar but complementary information to Raman 
spectroscopy. In this research, attenuated total reflectance fourier transform 
infrared (ATR-FTIR) spectra were collected from 4000 to 600 cm−1 for 64 
scans and 4 cm−1 resolution using a ZnSe crystal on a Bruker Tensor 27 FTIR 
spectrophotometer. 
2.8 Chemicals and materials 
MWCNTs (diameter 15 ± 5 nm and length 1-5 µm) and graphene (USA, 
diameter 5 μm) were purchased from NanoLab, Inc. (MA, USA) and Cheap 
Tubes (USA), and were used as such. APTES (98%), GOx (EC 1.1.3.4, type 
X-S from Aspergillusniger), D-glucose, 70% glutaraldehyde, 5% Nafion, 
dimethylformamide (DMF), K3Fe(CN)6, and the interfering substances were 
purchased from Sigma-Aldrich. Sugar-Chex Linearity (whole blood glucose 
linearity standards) was purchased from Streck, Inc. (USA). BupH 2-(N-
morpholino)ethanesulfonic acid buffered saline (MES), 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC) and BCA protein 
assay kit were procured from Thermo Scientific. APTES and glutaraldehyde 
were diluted in ultrapure water (UPW, 18.2 MΩ.cm@25 °C, Direct Q, 
Millipore); 0.5%Nafion was prepared in absolute ethanol; EDC solution was 
prepared in 100 mM MES while the dilution of GOx and glucose were made 
in 50 mM PBS, pH 7.4. 
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In the electrochemical experiments, GCEs (3 mm diameter, CH Instruments, 
Austin, TX, USA) were polished consecutively using 0.3 and 0.05 µm alumina 
powder, and subsequently cleaned by putting in an ultrasonic bath for 20 min 
before modification. In the SEM-EDX and ATR-FTIR experiments, a thin cell 
GCE (BASi, MF-1000, West Lafayette, IN) was used. The electrode (3 mm in 
diameter) contains a cylinder of electrode material embedded in a rigid 

















Chapter 3 Effect of 3-aminopropyltriethoxysilane on the 
electrocatalysis of carbon nanotubes for reagentless glucose 
biosensing 
3.1 Introduction 
    The amino group of APTES has been widely employed for electrode 
modification and bioconjugation [135-137]. To date, APTES has been 
advocated for diverse bioanalytical platforms with improved stability and 
sensitivity: continuous glucose monitoring systems [138-140], enzyme linked 
immunosorbent assays [141, 142], surface plasmon resonance-based assays 
[143], crystal microbalance-based assays [144], microarrays and 
immunoaffinity columns. However, except for its effect on the thermal 
stability of GOx [145], the effect of APTES concentration on the 
electrocatalysis of the electrochemical glucose sensing assay has not been 
addressed. 
CNTs have also been extensively used in analytical applications owing to 
their large surface area, high thermal conductivity, high mechanical strength, 
excellent optical and electrical properties, and cost-effectiveness [56]. The 
direct electron transfer between enzymes and an electrode surface facilitated 
by MWCNTs is useful towards the development of enzymatic biosensors with 
enhanced selectivity [146], low detection limit and rapid reaction kinetics. In 
electrochemical biosensing and drug delivery, APTES serves as dispersion [58] 
and/or functionalization [147] agent for MWCNTs. It is evident from the 
literature that various concentrations of APTES had been employed. For 
instance, 2% APTES (in acetone or water) was used to enhance the thermal 
stability of MWCNTs [148]; 2.5% APTES (in tetrahydrofuran) was used to 
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fabricate silica nanoparticles on functionalized MWCNTs [147]; 4.7% APTES 
(in dioxane) was used for the encapsulation of MWCNTs by a poly(3-
acrylaminopropylsiloxane) layer with silica nanospheres on the polymer 
surface [149]; 10% APTES (in ethanol) was applied to functionalize 
MWCNTs [150]; and 10% APTES (in the mixture of APTES, Nafion and 
ethanol) was used for the construction of a MWCNT-based GCE for glucose 
detection [58]. 
 
Fig. 3-1. Schematic of various APTES based electrochemical glucose 
biosensing formats. The notations 1, 2, and 3 refer to direct GOx, MWCNT 
(dispersed in DMF), and MWCNT (dispersed in APTES) based formats. 
 
This study provides a guided insight into the optimization of APTES-based 
chemistry applied in electrochemical glucose biosensor by critically evaluating 
the concentration effect of APTES on electrocatalysis of three electrochemical 
glucose biosensing assay formats (Fig. 3-1), whether it serves as a surface 
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modification and/or a dispersion agent. In brief, (i) GOx is directly adsorbed 
on APTES-functionalized GCE, (ii) MWCNTs [dispersed in DMF 
(dimethylformamide)] are bound to APTES-functionalized GCE followed by 
GOx adsorption, and (iii) MWCNTs (dispersed in APTES) are bound initially 
to GCE with GOx adsorbed thereafter. Our results unravel a significant effect 
of APTES on the above three biosensing formats, thereby making it absolutely 
essential to optimize the APTES concentration for a particular application. 
3.2 Preparation of various glucose biosensing formats 
    The GOx stock solution was prepared by mixing equal volumes of 10 mg 
mL-1 GOx and 5% glutaraldehyde, and was stored at 4 °C for at least 1 h prior 
to use. The direct GOx format was prepared as shown in route 1 (Fig. 3-1). 3 
µL of the APTES solution (0-10%, v/v) was drop cast on the GCE, dried at RT 
for 1 h, and washed extensively with UPW. After drop casting of 4 µL of GOx 
(in 2.5% glutaraldehyde) on the APTES-functionalized GCE, the resulting 
electrode was incubated for 1 h at RT and extensively washed with UPW. 
Finally, Nafion (3 µL of 0.5%) was drop cast, dried at RT for 10 min, and 
washed extensively with PBS. 
    The MWCNT (dispersed in DMF) format was prepared as shown in route 2 
(Fig. 3-1). The MWCNT suspension (3 μL, 1 mg mL-1), prepared by 
sonication of MWCNTs in DMF for 30 min, was drop cast on the APTES-
functionalized GCE (0.25-10%, v/v), dried at RT for 1 h, washed extensively 
with UPW, and then bound to GOx (in 2.5% glutaraldehyde) and Nafion, as 
described in route 1.  
    The MWCNT (dispersed in APTES) format was prepared as shown in route 
3 (Fig. 3-1).  MWCNTs (1 mg mL-1) were dispersed in varying concentrations 
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of APTES (0.06-10%, v/v) by sonication for 30 min. The resulting MWCNTs 
solution (3 μL) was drop cast on the GCE, dried at RT for 1 h, washed 
extensively with UPW, and then bound to GOx (in 2.5% glutaraldehyde) and 
Nafion, as described in route 1. 
3.3 Results and discussion 
3.3.1 Development and characterization of various glucose biosensing 
formats 
Table 3-1. Elemental analyses (weight %) of different electrodes 
Electrode C O Si F S 
GCE(bare) 95.5 4.5 - - - 
GCE(KOH) 94.8 5.2 - - - 
GCE(KOH)/APTES 
 
47.7 49.9 2.3 - - 
Route 1 
 
     
GCE(KOH)/APTES/GOx 
 
62.0 36.1 1.8 - - 
GCE(KOH)/APTES/GOx/Nafion 
 
40.7 15.0 0.2 43.8 0.4 
Route 2 
 
     
GCE(KOH)/APTES/MWCNT(DMF) 
 
74.6 23.4 2.1 - - 
GCE(KOH)/APTES/MWCNT(DMF)/GOx 
 




29.8 9.1 - 60.7 0.4 
Route 3 
 
     
GCE(KOH)/MWCNT(APTES) 
 
54.1 40.1 5.8 - - 
GCE(KOH)/MWCNT(APTES)/GOx 
 




42.9 18.6 0.5 38.0 0.1 
 




Fig. 3-2. ATR-FTIR spectra of different reaction intermediates deposited on 
the GCE surface. 
 
SEM-EDX analyses (Table 3-1) and ATR-FTIR spectra (Fig. 3-2) were 
used to confirm the deposition of specific materials on the surface of the GCE 
in each step. The treatment of the GCE with KOH resulted in a slight increase 
in oxygen content associated with the formation of hydroxyl groups on the 
surface of the glassy carbon. As shown in Fig. 3-1 Route 1, these hydroxyl 
groups formed silanol bonds (-O-Si-) with APTES [141], generating an 
amino-functionalized electrode surface. The addition of APTES led to an 
increase in oxygen content of 49.9%, with 2.3% weight content of Si. The 
FTIR spectrum of the amino-functionalized GCE (Fig. 3-2A) shows several 
important bands including 1556 and 1484 cm-1 (ν(NH2)), 1433 cm-1 (νs(CH3)), 
1383 cm-1 (νas(CH3)), and 1371 cm-1 (ν(CH2 backbone)) associated with the 
bound APTES [151]. Subsequently, the C-terminal of crosslinked GOx (N-
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terminal crosslinked by glutaraldehyde) interacted with the amino groups 
exposed on the GCE surface when it was drop cast on the APTES-
functionalized GCE. Fig. 3-2B shows the characteristic amide-I and amide-II 
bands of GOx centered at 1655 cm-1 and 1535 cm-1, respectively [152]. This 
result was the most compelling evidence for the immobilization of GOx on the 
APTES-functionalized GCE. In Fig. 3-1 Route 2, the suspension of MWCNT 
(dispersed in DMF) was added to the APTES-functionalized GCE surface, 
with GOx drop cast and adsorbed on the MWCNT (in DMF)-GCE surface. 
The addition of MWCNT led to a significant increase in carbon content from 
47.7% to 74.6% with new FTIR bands at 1141 cm-1 (νas(C-O)), 2976 cm-1 
(νs(CH2)) and 3015 cm-1 (νas(CH2)) attributed to defect sites on the CNT 
surface (Fig. 3-2C) [153]. In Fig. 3-1 Route 3, the suspension of MWCNT 
(dispersed in APTES) was first drop cast on the KOH treated GCE surface, 
and thereafter crosslinked GOx was adsorbed on the MWCNT (in APTES)-
GCE. It was anticipated that the FAD of GOx was strongly adsorbed onto the 
side walls of MWCNTs [154]. The amide-I and amide-II bands of the flavin 
group should overlap with the amide linkages of the enzyme. Lastly, Nafion 
was used as a glucose limiting membrane for all three formats. SEM-EDX 
analysis shows a significant increase in fluorine and sulfur content associated 
with Nafion, a sulfonated fluoropolymer with characteristic FTIR bands 
centered at 1213 cm-1 (νas(CF2)), 1139 cm-1 (νs(CF2)), 1053 cm-1 (νs(SO)), 981 




Fig. 3-3. Pictures of MWCNTs dispersed in (A) water and (B) APTES 
(0.125%), and the SEM images of (C) MWCNT (dispersed in DMF)-, and (D) 
MWCNT (dispersed in APTES)-functionalized glassy carbon. 
 
The comparison of using water (Fig. 3-3A) and APTES (Fig. 3-3B, 
concentration of APTES = 0.125%) as dispersion agents for MWCNTs clearly 
showed that MWCNTs formed a uniform suspension in APTES but 
aggregated in water. This demonstrates the capability of APTES in dispersing 
MWCNTs. The SEM images of the MWCNTs (dispersed in DMF or APTES) 
modified glassy carbon were shown in Fig. 3-3C and D, illustrating uniform 




Fig. 3-4. (A) CVs of Nafion/APTES(2%)/GCE (dash-dot-dot), direct GOx 
(dash), MWCNT (dispersed in DMF) (solid), and MWCNT (dispersed in 
APTES) (dot) formats in 50 mM PBS at 100 mV s-1 in the presence of nitrogen. 
(B) CVs of 0 mM (dash) and 4 mM (solid) glucose detected on MWCNT 
(dispersed in DMF) format. (C) Amperometric curves of varying 
concentrations of glucose on the MWCNT (dispersed in DMF) format in 50 
mM PBS at -0.45 V vs. Ag/AgCl. 
 
In nitrogen-saturated environment, DET of GOx was observed on both 
MWCNT-based formats, as shown in Fig. 3-4A. The DET of GOx observed 
on both MWCNT-modified electrodes could be facilitated by the three 
dimensional structure of MWCNTs which led to a shortened tunneling 
distance for the electron transfer of enzymes [100]. In the presence of oxygen, 
as the oxygen was consumed by the reaction between glucose and the 
reduction form of GOx (i.e. FADH2-GOx), the concentration of oxygen near 
the electrode surface was reduced, resulting in the decline in the reduction 
current with an increase in the glucose concentration [129, 146]. Therefore, 
the proportionate decrease in the cathodic current with the increase in the 
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glucose concentration was observed in all three sensing formats. Fig. 3-4B 
illustrates the CVs of 0 and 4 mM glucose, respectively, detected on electrode 
of the MWCNT (dispersed in DMF) format. The proportionate decrease of the 
reduction current with the increase in the glucose concentration was employed 
to determine the glucose levels using amperometric measurement in the 
presence of oxygen. Fig. 3-4C shows the amperometric response of 1-32 mM 
glucose detected on the same MWCNT sensing format. 
3.3.2 Effect of APTES on electrochemical glucose biosensing 
 
Fig. 3-5. Effect of varying APTES concentrations on the performance of three 
different glucose biosensing formats: (A) Direct GOx; (B) MWCNT 
(dispersed in DMF); and (C) MWCNT (dispersed in APTES) formats. (D) 
Overlay plot of various formats based on the optimized APTES concentration 
for a particular format. The error bars shown in (A, B, C, D) represent 
standard deviation (SD). 
 
In the direct GOx format, the results shown in Fig. 3-5A clearly 
demonstrate that 2% APTES was the most appropriate for GCE surface 
modification. The steady current (Isteady) of glucose was appreciably lower 
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when APTES concentrations less than 2% were used as the GCE surface was 
not saturated with APTES. In contrast, there was the formation of multilayers 
if APTES concentrations were greater than 2% [141, 156, 157]. The additional 
APTES molecules in such multilayers might not be correctly oriented, i.e., the 
random orientation of their amino groups was unfavorable for GOx binding, 
leading to lower signal responses. The 2% APTES-functionalized GCE based 
glucose sensing strategy gave rise to 4-fold higher Isteady for the detection of 4 
mM glucose compared to the APTES-minus control. It should be noted that 
similar results have been reported for immunoassays on APTES-
functionalized surfaces [141, 143], where 2% APTES was considered as the 
optimum concentration for surface modification. 
In the MWCNT (dispersed in DMF) format, the optimal APTES 
concentration was shown to be 1% (Fig. 3-5B). The response signal was 
adversely affected at higher APTES concentrations. Evidently, there was an 
increase in the steric hindrance between MWCNTs due to the increased 
number of surface-induced amino groups of APTES as well as the formation 
of multilayers with randomly oriented APTES molecules. Our findings 
corroborated with the previous reports [158, 159] pertaining to different assay 
formats, illustrating that there is an optimum density of surface-induced 
functional groups or surface-bound molecules for a particular application. The 
use of a higher density of surface-induced functional groups or surface-bound 
molecules can cause steric hindrance for the binding of capture molecules, 
thereby resulting in decreased assay sensitivity. Note that the Isteady for glucose 
sensing by the MWCNT (dispersed in DMF) format was about 10-fold higher 
compared to the signal response obtained by the direct GOx format. This 
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excellent electrocatalytic effect could be attributed the increase in the surface 
area contributed by MWCNTs and the greater GOx binding to MWCNTs. 
    The MWCNT (dispersed in APTES) format determined the effect of 
APTES concentrations on the electrochemical glucose sensing, when it was 
used for the dispersion of MWCNTs. The Isteady of glucose (Fig. 3-5C) shows 
that 0.125% APTES was the most appropriate concentration for the dispersion 
of MWCNTs. Notice also that in the previous reports [58], 10 % APTES has 
been used for the dispersion of MWCNTs. The Isteady for the detection of 4 
mM glucose was about 8-fold higher when 0.125% APTES was used in 
comparison to 10% APTES. 
    Thus, the optimization of the APTES concentration for the dispersion of 
MWCNTs was essential for a particular sensing application. An in-depth 
future analysis to study the structural changes in MWCNTs in response to 
their dispersion in varying concentrations of APTES might provide a further 
insight and understanding into the nature of dispersion-associated effects. 
However, the MWCNT (dispersed in DMF) format using 1% APTES provides 
greater current signal than the MWCNT (dispersed in 0.125% APTES) format. 
It has been demonstrated that the use of APTES-functionalized platforms leads 
to a higher enzyme immobilization density. Hence, the MWCNT (dispersed in 
DMF) format on the APTES-functionalized GCE might have greater MWCNT 
and/or GOx immobilization density in comparison to the MWCNT (dispersed 
in 0.125% APTES) format. Therefore, BCA protein assay was employed to 
compare the total GOx content on the MWCNT (dispersed in DMF) and 
MWCNT (dispersed in APTES) formats (data not shown). The higher 
absorbance observed in the BCA mixture treated with MWCNT (dispersed in 
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DMF) format (0.92) than that treated with MWCNT (dispersed in APTES) 
format (0.72) demonstrates the denser immobilization of GOx on the former 
format of modified electrodes. Fig. 3-5D compares the analytical performance 
for the three glucose sensing formats employed in this study. It could be 
implied that the use of MWCNTs provides greater current signal enhancement 
by providing greater surface area for enzymatic binding, whereas electrode 
silanization increases the enzyme immobilization density by providing greater 
surface functional groups. Moreover, compared to published MWCNT-based 
glucose biosensors, the MWCNT (dispersed in DMF) format provides wider 
glucose detection linear range (1-16 mM) [63, 160-164].  
3.3.3 Analytical performance of the MWCNT (dispersed in DMF) format 
 
Fig. 3-6. Use of MWCNT (dispersed in DMF) based format for 
electrochemical glucose sensing. (A) Detection of Streck blood glucose 
linearity standards. The steady current Isteady/µA (ordinate) is presented as a 
function of the log scale of glucose concentration Log[Gluc]/mM (abscissa). 
(B) The effect of physiological interferences and medications on the specific 
detection of glucose. The error bars shown in (A, B) represent SD. 
 
The MWCNT (dispersed in DMF) format was found to be the best in terms 
of glucose linear range (1-16 mM). It was critically evaluated for 
electrochemical glucose sensing using Sugar-Chex blood glucose linearity 
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standards (Streck, USA), which have the same composition of components as 
found in human blood but they are highly stable. The GOx-bound GCE 
prepared by MWCNT (dispersed in DMF) based format successfully detected 
the entire set of Sugar-Chex blood glucose standards in the range of 1.4-28 
mM (Fig. 3-6A), which covered the entire pathophysiological glucose range in 
humans. An attempt to correlate the current response (Ip) and glucose 
concentration (C) by the hyperbolic equation Ip = IpmaxC/(Kd + C) only resulted 
in a correlation coefficient of R2 = 0.93 with Ipmax (13.28 μA) as the maximum 
current response and Kd (0.82 mM) as the dissociation constant. It was 
determined that Ip was correlated well with the log scale of the glucose 
concentration as Isteady (μA) = (8.44 ± 0.11) + (3.46 ± 0.12) log [C] (mM) with 
a correlation coefficient of R2 = 0.999 at a 95% confidence interval. Note that 
only a small fraction of glucose was consumed by the enzyme and the 
calibration correlation was for total glucose. Also notice that the MWCNTs 
(dispersed in DMF) based glucose sensor provided a wider detection range 
and greater current signal when it was used to detect blood glucose. This was 
due to the reaction kinetics of Sugar-Chex blood glucose on the electrode 
surface was different from that of chemical glucose. Sugar-Chex blood 
glucose exhibited the same hematocrit, viscosity, and surface tension as that of 
human whole blood. But the chemical glucose was incapable of mimicking 
these parameters, and hence adversely affected the reaction kinetics of glucose 
oxidation on the electrode surface [165]. Therefore, the developed format was 
suitable for glucose monitoring in diabetics. Moreover, the developed 
electrochemical glucose sensing method was not affected by various 
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biologically interfering substances, drugs and non-glucose sugars (Fig. 3-6B) 
as it was mediatorless and employed low applied potential (-0.45 V).  
 
Fig. 3-7. The bioanalytical performance of the MWCNT (dispersed in DMF) 
glucose sensing format. (A) Production reproducibility on 25 GCEs. (B) BCA 
protein assay for the determination of GOx binding on electrode for 9 weeks. 
(C) Stability of the electrode that was stored at RT in dry state for 5 weeks. (D) 
Continuous monitoring of 4 mM glucose for 150 times using the same 
electrode. The error bars shown in (A, B, C) represents SD. 
 
Our developed strategy has high production reproducibility, which was 
demonstrated by the highly reproducible glucose sensing response on 25 
freshly prepared glucose sensing GCEs (Fig. 3-7A). The BCA protein assay 
(Fig. 3-7B) further demonstrated the leach-proof binding of GOx to the 
MWCNT-functionalized GCE for 9 weeks. The GOx-bound MWCNT-
functionalized GCE, stored at RT in the dry state, did not show any decrease 
in functional activity for about 3 weeks and only 5 % decrease after 5 weeks 
(Fig. 3-7C). Such a glucose biosensor was ideal for continuous glucose 
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monitoring as it detected 4 mM glucose consecutively for 150 times without 
incurring any decrease in signal (Fig. 3-7D). 
3.4 Conclusions 
    The optimal effect of APTES concentration was investigated in depth on the 
three different glucose biosensing formats. Our results clearly demonstrate that 
the screening of an optimum APTES concentration is the most critical step for 
electrochemical glucose biosensing as it drastically affects the glucose 
detection response. The developed MWCNT (dispersed in DMF) based 
glucose sensing strategy is suitable for diabetic blood glucose monitoring as it 
provides good electrocatalysis to glucose sensing and detects the entire 
pathophysiological range of glucose in humans. It is virtually unaffected by 
biologically interfering substances and drugs as it is mediatorless and employs 
-0.45 V applied potential. Similar biosensor formats can also be developed for 
the detection of other important analytes, such as cholesterol, alcohol, lactate, 
acetylcholine, choline, hypoxanthine, and xanthine, which are also based on 











Chapter 4 Mediatorless amperometric glucose biosensing using 
3-aminopropyltriethoxysilane-functionalized graphene 
4.1 Introduction 
    Graphene has been widely applied in the field of optoelectronic devices 
[166], supercapacitors [167] and various high performance sensors [168-173] 
due to its large surface area-to-volume ratio [55, 174], excellent electrical 
conductivity, small band gap and high electron mobility [175]. The large 
surface area of graphene can increase the surface loading of desired 
biomolecules such as enzymes and proteins, while the excellent conductivity 
of graphene may improve the conduction of electrons between biomolecules 
and electrode surface [175]. Moreover, it has been demonstrated that graphene 
is more cost-effective than carbon nanotubes since they can be conveniently 
synthesized from graphite [80].  
Kang et al. [79] and Wang et al. [81] had observed the DET between 
oxidoreductase and electrode surface in graphene-based mediatorless 
electrochemical glucose biosensors [79, 81]. GOx was found to undergo a 
reversible two-proton and two-electron transfer reaction, at a rapidly 
heterogeneous electron transfer rate with rate constant of 2.83 s−1, when it was 
bound to the graphene-chitosan modified GCE [81]. The direct 
electrochemistry of GOx was also accessible in a polyvinylpyrrolidone-
protected graphene-ionic liquid [79] and an electrochemically reduced 
graphene oxide [176] modified GCE. The redox peaks of GOx active centers 
were also observable when GOx was immobilized on graphene-metallic 
nanoparticles composites with gold [176] or cadmium sulfide (CdS) [177]. 
However, these graphene-based electrodes employed lengthy procedures with 
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long preparation time of more than 24 h [79, 176-178] and were unable to 
detect the entire diabetic pathophysiological glucose range of 0.5-32 mM [79, 
81, 176, 177, 179], which render these approaches unsuitable for diabetic 
glucose monitoring. Moreover, most of the reported graphene-based 
electrochemical sensors had employed an organic or inorganic solvent, such as 
dimethylformamide [178], dichlorobenzene [180], acetic acid [181] and 
chitosan [176, 182], for the dispersion of graphene. To the best of our 
knowledge, APTES has not been employed for dispersing graphene. 
 
Fig 4-1. Schematic diagram of the graphene based glucose biosensor. 
 
We report here a simple bioanalytical procedure (Fig. 4-1) for the rapid 
preparation of GOx-bound graphene-functionalized GCEs in less than 4 h. It 
involved sequentially the generation of hydroxyl groups on GCE by treatment 
with 1% KOH; graphene functionalization of GCE by incubating the KOH-
treated electrode with graphene dispersed in APTES; GOx binding by EDC 
based heterobifunctional crosslinking to graphene-functionalized GCE; and 
56 
 
covering the GOx-bound GCE with 0.5% Nafion. Nafion acted as a glucose-
limiting membrane, which allows the diffusion of glucose molecules but 
prevents the diffusion of larger contaminating substances and interferences. 
The proposed graphene-based biosensor was then employed for the 
amperometric detection of commercial as well as standardized blood glucose 
in the clinically-relevant pathophysiological range in diabetic monitoring. The 
production reproducibility of the developed bioanalytical procedure was also 
determined along with the storage stability of the graphene-based glucose 
biosensor. 
4.2 Preparation of graphene-based glucose biosensor 
The GOx stock solution was prepared by mixing equal volumes of 10 mg 
mL-1 GOx and 5% glutaraldehyde, and then stored at 4 °C for at least 1 h prior 
to use.  GCEs were dipped in 1% KOH for 5 min to generate hydroxyl groups 
on their surface, and then washed extensively with UPW. 1 mg of graphene 
was mixed with 1 mL of 0.125, 0.25, 0.5, 1, 2, 4, 6, 8 and 10% APTES and 
dispersed in ultrasonic bath for 1 h. 4 μL of the resulting graphene-APTES 
suspension was drop cast on GCE surface, incubated at RT for 1 h, and 
washed extensively with UPW to form graphene-APTES/GCE. Thereafter, 4 
μL of EDC-activated GOx (5 mg mL-1) was drop casted on each graphene-
APTES/GCE, incubated at RT for 1 h, and washed extensively with PBS to 
form GOx/graphene-APTES/GCE. Finally, 3 μL of 0.5% Nafion was 
employed, incubated at RT for 10 min, and washed extensively with PBS to 
form Nafion/GOx/graphene-APTES/GCE. 
4.3 Results and discussion 
4.3.1 Development of graphene-based glucose biosensor 
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The graphene-based glucose biosensor was designed using a simple 
bioanalytical procedure, which enabled the rapid preparation of 
Nafion/GOx/graphene-APTES/GCEs. The procedure was based on the use of 
APTES, which acts as a dispersion agent for graphene and as a surface 
modification agent for GCE and graphene. APTES is well known as a surface 
modification agent for inducing free amino groups that can be used for the 
EDC-sulfo NHS based crosslinking of antibodies [141, 143, 156] on various 
bioanalytical platforms. Nevertheless, the rapid one-step preparation of 
graphene-functionalized GCE by incubating with graphene dispersed in 
APTES has not been demonstrated. In this strategy, APTES in the graphene 
sample binds to the hydroxyl groups on the GCE surface and graphene by its 
alkoxy groups, while its amino groups on the other end are free for 
crosslinking to GOx.  
 
Fig. 4-2. FTIR spectra of (a) pH 9 APTES-graphene, (b) APTES-graphene and 
(c) pristine graphene in the region of (A) 4000-400, (B) 3100-2800 and (C) 




Fig. 4-2 shows the FTIR spectra of pristine and APTES-functionalized 
graphene. As illustrated in Fig. 4-2A, the FTIR spectrum of pristine graphene 
was virtually featureless with the exception of the ~1650 cm-1 peak associated 
with the skeletal vibrations of the graphitic sheet [183, 184]. The free primary 
amine NH2 bending mode of APTES at 1600 cm-1 could not be discernible 
from the FTIR of the graphene-APTES sample due to the overwhelming 
signal of graphene at this wavelength. CH3 asymmetric stretching at ~2970 
cm-1, CH2 asymmetric stretching of APTES at ~2930 cm-1  and the NH2 
stretch vibration of APTES at 3350-3380 cm-1 [185] were overlapped by the 
strong peak of pristine graphene (Fig. 4-2B). Nevertheless, the FTIR signature 
of APTES-graphene was distinctly different from that of graphere in the 
region of 700-1000 cm-1 (Fig. 4-2C), exemplified CH3 rocking (~740 cm-1) 
and H-SiO3 bending (887 cm-1). Such a difference indicates the interaction 
between graphene and APTES to form a stable complex on the electrode 
surface. When the graphene dispersed in APTES is provided to GCE, the 
APTES molecules functionalized on GCE surface and on graphene can form 
siloxane bonds (-Si-O-Si-), thereby resulting in the functionalization of GCE 
with graphene. GOx is then covalently bound to graphene-APTES/GCE by 
EDC-based crosslinking. Initially, GOx is incubated with EDC for 15 min, 
which crosslinks EDC to the carboxyl groups on GOx and forms EDC-
activated GOx. Subsequently, the EDC-activated GOx is provided to 
graphene-APTES/GCE, which leads to the formation of covalent amide bond 
between the carboxyl group on GOx and the free amino groups on the 
graphene-APTES/GCE. The GOx/graphene-APTES/GCE is finally covered 
with a thin layer of 0.5% Nafion as glucose limiting membrane. As a control, 
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the same bioanalytical procedure was used for the direct crosslinking of GOx 
to 2% APTES-functionalized GCE without employing graphene (denoted as 
Nafion/GOx/GCE). 
Fig. 4-3A and B are the photographs showing graphene-APTES suspension 
and graphene-water mixture. Graphen was found to be well-dispersed in 
APTES (Fig. 4-3A), whereas form aggregates in water (Fig. 4-3B). The SEM 
image (Fig. 4-3C) of graphene functionalized glassy carbon substrate clearly 
shows the flake-like structure of graphene, which were uniformly bound to the 
glassy carbon. 
 
Fig. 4-3. Graphene dispersed in (A) APTES, and (B) water. (C) SEM image of 
graphene-functionalized glassy carbon substrate (the inlet is the SEM image of 
blank glassy carbon). 
 
4.3.2 Detection of glucose and blood glucose 
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The developed electrode was characterized by CV in the absence and 
presence of oxygen before it was used for glucose detection. The results are 
shown in Fig. 4-4A and B. No redox peaks of FAD/FADH2 were observed in 
Nafion/GOx/graphene-APTES/GCE whether N2-saturated (Fig. 4-4A) or 
ambient PBS (Fig. 4-4B) was employed. However, the cathodic current (from 
-0.2 to -0.8 V) decreased with the increase in glucose concentration in the 
presence of oxygen (Fig. 4-4B). The decrease in cathodic current is attributed 
to the GOx-FADH2 catalyzed reduction of oxygen [100, 186]. Additionally, 
such proportionate decrease in cathodic current with the increase in glucose 
concentration can be employed for amperometric detection of glucose. The 
effect of applied potential on glucose sensing was also determined (Fig. 4-5A) 
and the optimum potential was found to be -0.45 V. The amperometric 
responses of the developed electrode for the detection of 1-32 mM glucose are 
shown in Fig. 4-5B. 
 
Fig. 4-4. (A) CVs of (a) Nafion/graphene-APTES/GCE and (b) 
Nafion/GOx/graphene-APTES/GCE in N2-saturated 50 mM PBS. (B) CVs of 
Nafion/GOx/graphene-APTES/GCE in 0, 1 and 4 mM glucose solutions in the 





Fig. 4-5. (A) Optimization of applied potential for the electrochemical 
detection of 4 mM glucose using Nafion/GOx/graphene-APTES/GCE. (B) 
Amperometric detection of 1-32 mM glucose at -0.45 V in the presence of 
oxygen. The error bars shown in (A) represent SD. 
 
We have previously investigated the concentration effect of APTES on 
various glucose sensing strategies with and without using carbon nanotubes 
[187], and found that there was a particular APTES concentration which was 
optimum for different strategy. In the present study, where APTES was used 
both as surface modification and dispersion agent for graphene, 0.125% 
APTES was found to be the optimum concentration (Fig. 4-6A). The 
developed amperometric glucose biosensor had a dynamic range of 0.5-32 
mM with linearity of 1-32 mM that covers the entire diabetic 
pathophysiological range of 1-28 mM. The current response of developed 
Nafion/GOx/graphene-APTES/GCEs for the detection of glucose was much 
higher than that of Nafion/GOx/GCE (Fig. 4-6B). This result indicates the 
signal enhancement provided by graphene attributed to the increased electrode 
surface area and thus leads to higher GOx immobilization density. Moreover, 
the developed bioanalytical procedure for the preparation of 
Nafion/GOx/graphene-APTES/GCEs takes the same hands-on time as that of 
Nafion/GOx/GCE because graphene functionalization of GCE follows the 




Fig. 4-6. (A) Effect of APTES concentration on the electrochemical glucose 
sensing by the graphene-based glucose biosensor. (B) Comparison of 
electrochemical glucose sensing by Nafion/GOx/graphene-APTES/GCE and 
Nafion/GOx/GCE. (C) Detection of Sugar-Chex whole blood glucose linearity 
standards by the Nafion/GOx/graphene-APTES/GCE. The error bars shown in 
(A, B, C) represent SD. 
 
It is important to evaluate the performance of a glucose biosensor on 
clinical sample analysis. However, only a few studies regarding graphene-
based glucose biosensor reported the detection of varying glucose 
concentrations in human serum samples [82, 177]. Hence, the developed 
glucose biosensor was further investigated for its capacity of detecting blood 
glucose using Sugar-Chex blood glucose linearity standards, which are widely 
used as the industrial calibration and clinical validation standards for diabetic 
blood glucose monitoring. Streck blood glucose standards highly mimic the 
actual blood glucose reaction kinetics on electrode surface, which is 
distinguished from that of commercial glucose [165, 188]. The developed 
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biosensor detected the entire set of blood glucose linearity standards in the 
range of 1.4-27.9 mM (Fig. 4-6C), which demonstrates its clinical utility for 
diabetic blood glucose monitoring. The relation between current signal (Isteady) 
and glucose concentration (log[Gluc]) can be expressed as Isteady (µA) = (1.97 
± 0.12) + (3.45 ± 0.11) log[Gluc] (mM). Moreover, the current signals for the 
detection of blood glucose standards are higher than those of commercial 
glucose as expected, which may be attributed to the matrix effect [165, 188], 
as mentioned above. Also, these results warrant the need to determine the 
analytical biosensing parameters of glucose biosensing approaches using the 
blood glucose only instead of the commercial glucose that has been used in 
many published reports.  The developed glucose biosensor was found to have 
the best dynamic and linear range in comparison to other graphene-based 
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ascorbic acid, uric 
acid, dopamine and  
acetaminophen, 
relative to 2 mM 
glucose  
N.M.* Stored at 4 °C in 
0.1 M PBS (pH 
7.0),  93% of 
initial response 



















from 0.2 mM of 
ascorbic acid and 
uric acid, relative 
to 5 mM glucose 












Stored at 4 °C, 
80% of initial 
response retained 





N.M.* Amperometry,  
(+0.4 V) 
0-22 N.M.* N.M.* Stored at 4 °C in 
PBS,  80% of 
sensitivity 






>4 CV  
(-0.65 to -0.2 
V vs. saturated 
calomel) 
electrode) 
0.1-10 N.M.* Sensor was 
used to detect 
blood glucose 






Stored at 4 °C in 
PBS, no obvious 












(-1.0 to +0.2 
V) 




sample in the 
presence of 
2.5- 7.5 mM 
glucose 
Stored at 4 °C,  
83% of initial 
response retained 






(-0.7 to  -0.1 
V) 
2-16 Negligible signals 
from 0.1 mM 
ascorbic acid and 
0.5 mM uric acid, 
relative to 5 mM 
glucose 
Recovery test 
were done in 
human plasma 
sample for 
adding 1 mM 
and 2 mM 
glucose, with 
the recoveries 
of 92.2% and 
105.1%  
Stored at 4 °C in 
0.05 M PBS,  
93% of initial 
response retained 











>20 CV  
(-0.8 to  -0.1 
V) 
0.5-10 N.M.* Recovery test 
were done in 
human serum 
sample for 




Stored at 4 °C in 
0.1 M PBS,  
96.2% of initial 
response retained 











At applied potential 
of -0.05 V, 
negligible signals 
from 0.2 mM of 
ascorbic acid and 
0.5 mM of uric 
acid, relative to 5 
mM glucose 
Recovery test 










Stored at 4 °C in 
0.05 M PBS,  
80% of initial 
response retained 
after three weeks 
[181] 
*applied potential: refers to Ag/AgCl, if not specified. 





4.3.3 Effect of interfering substances 
The interference of glucose biosensor is one of the most critical analytical 
parameters that determine the commercial success of blood glucose 
monitoring devices [5, 192-195]. However, most of the reported graphene-
GOx based glucose biosensors had either not tested [79, 81, 176] or employed 
only a few interfering substances [82, 83] such as ascorbic acid, uric acid, 
dopamine and acetaminophen. In this study, the effects of various interferents 
on the detection of glucose by the developed biosensor were critically 
investigated (Fig. 4-7). It was found that the pathophysiological levels of 
biologically interfering substances and drug metabolites [196] did not interfere 
with the detection of glucose by the developed biosensor. Moreover, no 
interference was observed from the therapeutic levels of non-glucose sugars 
[197]. The absence of interference from most common interferents indicates 
the high precision of blood glucose measurements by the developed biosensor 
for diabetic monitoring. 
 
Fig. 4-7. Effect of interfering substances on the specific detection of 6.8 mM 





4.3.4 Analytical performance of the graphene-based glucose biosensor 
The capability of the proposed procedure for reproducible mass-production 
of GOx-bound graphene-functionalized GCEs was tested by preparing 25 
Nafion/GOx/graphene-APTES/GCE and employing them for the triplicate 
detection of 4 mM glucose. As shown in Fig. 4-8A, the proposed strategy has 
excellent production reproducibility, which is ideal for the commercial mass-
production. It can be easily transduced to screen- or inkjet-printing, which are 
cheaper techniques for the commercial mass-production of enzyme-bound 
electrodes [198-200]. The screen-printing will enable the production of 
graphene-APTES/GCE, GOx/graphene-APTES/GCE and 
Nafion/GOx/graphene-APTES/GCE in consecutive steps. 
 
Fig. 4-8. (A) Production reproducibility of the graphene-based glucose 
biosensing procedure. (B) Determination for stability of 
Nafion/GOx/graphene-APTES/GCEs that were stored at RT in dry. (C) BCA 
protein assay for the determination of GOx binding on electrodes for 9 weeks.  
(D) Determination of the effect of biofouling. The error bars shown in (A, B, 




The storage stability of the developed Nafion/GOx/graphene-APTES/GCE, 
stored at RT under ambient conditions, was determined from the current 
response pertaining to the detection of 8 mM glucose each week for the 
duration of 5 weeks (Fig. 4-8B). There was no decrease in the current 
response of developed Nafion/GOx/graphene-APTES/GCE for the first 3 
weeks and only a minor decrease of 12% in the next 2 weeks. The decrease in 
the functional activity after 3 weeks may be due to the spreading of GOx and 
its conformational change under ambient conditions [141]. This storage 
stability demonstrates the developed laboratory prototype of glucose biosensor 
under ambient conditions. However, more intensive studies are underway to 
determine the actual shelf-life of developed Nafion/GOx/graphene-
APTES/GCEs employing the commercial strategies being employed for 
storage and packing. Various strategies are also being tried to prolong the 
shelf-life of developed Nafion/GOx/graphene-APTES/GCEs, which will be a 
key determinant for their commercialization. The total concentration of GOx 
bound to graphene-functionalized GCE, as determined by BCA protein assay, 
was found to be consistently uniform for 2 months (Fig. 4-8C), which 
confirmed the leach-proof binding of GOx to graphene-functionalized GCE by 
the proposed procedure. Moreover, there was no effect of biofouling when the 
developed Nafion/GOx/graphene-APTES/GCE was kept immersed in 1 mM 
Sugar-Chex blood glucose linearity standard for 7 days and used each day for 
the detection of 6.8 mM Sugar-Chex blood glucose linearity standard in 
triplicate (Fig. 4-8D). Therefore, the developed method will be of tremendous 
utility for the development of continuous glucose monitoring devices based on 
its higher analytical performance and stability in comparison to the 
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commercially-available continuous blood glucose monitoring devices, where 
the enzyme-coated electrode normally is used for 5 days. 
4.4 Conclusions 
    A simple bioanalytical procedure was developed for the preparation of 
Nafion/GOx/graphene-APTES/GCE that was employed for the mediatorless 
amperometric glucose biosensing in diabetic pathophysiological range of 0.5-
32 mM using redox potential of -0.45 V. The developed biosensor was 
validated for detecting blood glucose in Sugar-Chex blood glucose linearity 
standards (1.4-27.9 mM), and was demonstrated to be free from any potential 
interference by physiological substances, drug metabolites and non-glucose 
sugars. There was no decrease in functional activity of developed biosensor 
for three weeks, when it was stored in dry state at RT. However, the 
concentration of GOx bound to graphene-functionalized GCEs remained 
consistently constant for nine weeks, which shows the leach-proof binding of 
GOx to GCE by the developed procedure. This procedure also exhibited 
excellent production reproducibility for the preparation of graphene-based 
glucose biosensor and should be easily transduced to screen-printing that will 
enable the cost-effective mass-production of the biosensor for 
commercialization. There was no effect of biofouling on the glucose detection 
of Nafion/GOx/graphene-APTES/GCE for seven days. In summary, it has 
tremendous commercial potential for the development of diabetic blood 






Chapter 5 Rapid and simple preparation of a mediatorless 
glucose electrochemical biosensor 
5.1 Introduction 
    Continuous glucose monitoring systems (CGMS) play an important role in 
diabetes management due to a better glycemic control by continuous 
monitoring of fluctuations in blood glucose levels, which is otherwise not 
available by point-of-care glucose meters [201]. Real-time CGMS can provide 
useful insights to diabetic healthcare professionals for the effective 
management of diabetes [7, 201] to circumvent harmful complications. CGMS 
have not been overwhelmingly accepted by diabetics due to their high cost 
[202]. In brief, the high cost of CGMS can be attributed to the efforts required 
to improve sensing stability [203], accuracy, reliability and other bioanalytical 
parameters.  
In most commercial CGMS such as Guardian REAL-Time (Medtronic 
MiniMed, Sylmar, CA), DexComTM STSTM-7 (DexCom, San Diego, CA), 
and FreeStyle Navigator® (Abbott Diabetes Care, Alameda, CA), flavin-
containing glucose oxidase has been extensively used (Eq (5-1)). The 
molecular oxygen, O2, acts as a natural electron acceptor to oxidize the 
reduced form of GOx or GOx-FADH2 back to GOx-FAD (Eq (5-2)). The 
concentration of H2O2, a by-product of the enzymatic reaction, is measured 
and equated to the glucose concentration [5, 7]. Alternatively, if a mediator is 
used to facilitate the electron transfer between the active center of GOx and 
the electrode, the GOx-FADH2 can be oxidized electrochemically through the 
electrode reaction [5, 7, 8, 204] (Eq (5-3) and (5-4)). Although mediator based 
chemistry has been used in commercial blood glucose monitoring devices [5, 7, 
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204, 205], the search for an ideal mediator has not been fruitful. The mediator 
must be insoluble, non-toxic and chemically stable in both reduced and 
oxidized forms [4]. It must be firmly retained on the electrode for repeated use 
[8] and should not interact with endogenous electroactive substances and drug 
metabolites commonly found in blood [4]. 
Glucose + GOx-FAD → δ-Gluconolactone + GOx-FADH2        (5-1) 
GOx-FADH2 + O2 → GOx-FAD + H2O2                                    (5-2) 
GOx-FADH2 + 2Mox →GOx-FAD + 2Mred + 2H+ + 2e-            (5-3) 
2Mred → 2Mox + 2e-                                                                      (5-4) 
For the past decades, various efforts have focused on the GOx 
immobilization on a solid support with a minimal effect on its functional 
performance. Of interest is the use of chitin- and chitosan-based materials 
[206], conducting polymers [207, 208] (e.g. polyaniline and polypyrrole), sol-
gel encapsulation [209, 210] and other methods such as enzyme wiring [5, 7, 
8]. However, such methods employ time-consuming and complex chemical 
procedures, resulting in an increased manufacturing cost for the preparation of 
GOx-bound electrodes. Therefore, a highly convenient, leach-proof and 
reproducible procedure is needed for mass production of highly stable and 
interference- and biofouling-resistant GOx-bound electrodes. 
We describe here a simple and rapid procedure for the development of 
mediatorless GOx-bound electrodes, applicable for the detection of glucose in 
the diabetic pathophysiological range. The GOx-bound GCE was employed 
for the detection of commercial and blood glucose. The procedure 
reproducibility, storage stability, biofouling and the effect of physiological 
interferences were also investigated. The developed procedure will be of 
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tremendous significance for the rapid preparation of leach-proof enzyme-
bound electrodes for the detection of other analytes. 
5.2 Preparation of the simple and rapid glucose biosensor 
Crosslinked GOx was prepared by mixing equal volumes of 20 mg mL-1 
GOx and 5% glutaraldehyde solution followed by storage at 4 °C for at least 1 
h prior to use. GCE was dipped in 1% KOH for 5 min to generate hydroxyl 
groups on its surface. 2 μL of 10 mg mL-1 crosslinked GOx was drop cast on 
GCE followed by the immediate drop-casting of 2 μL of 4% APTES to form 
an APTES-GOx mixture on GCE. The APTES-GOx/GCE was dried at RT for 
1 h, washed extensively with 50 mM PBS and drop-casted with 3 μL of 0.5 % 
Nafion to form a Nafion/APTES-GOx/GCE. The developed procedure is 
illustrated in Fig. 5-1. 
 
Fig. 5-1. Schematic diagram for the preparation of a simple and rapid GOx-
bound GCE. 
 
5.3 Results and discussion 
5.3.1 Development of the simple and rapid glucose biosensor 
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The APTES-functionalized bioanalytical platforms have several potential 
advantages such as long-term stability, high immobilization density, less 
biofouling and high reproducibility. APTES has been used commercially for 
the development of highly stable continuous glucose monitoring systems [138-
140]. In this strategy, APTES is used for GCE surface modification and GOx 
binding for the development of a highly simplified procedure for glucose 
biosensing. As shown in Fig. 5-1, GOx was drop cast on the KOH-treated 
GCE surface, followed by immediate drop casting of APTES. In the micro-
environment of the droplet mixture, the amino group of APTES bound 
covalently to the carboxyl group of GOx, whereas the alkoxy groups bound to 
the hydroxyl groups generated on the KOH-treated GCE. Therefore, GOx was 
covalently bound to the GCE surface in a leach-proof manner. Moreover, as 
no artificial mediator is used, the electrochemical glucose sensing by the 
developed simplified procedure is based on Eq (5-1) and (5-2). To the best of 
our knowledge, the developed procedure is the most rapid method (about 1.5 h) 
up till date for the preparation of glucose biosensor in comparison to the 
procedures used in the published reports. 
As shown in Fig. 5-2A, in the presence of oxygen, although the redox peaks 
of GOx were not observed, the CVs of the glucose sensor show the maximum 
cathodic current in the absence of glucose (in the potential window of -0.3 to -
0.5 V). Additionally, the cathodic current decreased with the increase in 
glucose concentration. The reduction wave actually corresponds to the 
FADH2-GOx catalysed reduction of O2. As the oxygen was consumed by the 
reaction between glucose and GOx (Eq (5-2)), the concentration of oxygen 
near the electrode surface was reduced, resulting in the decline in reduction 
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current with an increase in glucose concentration. Our result is in good 
accordance with the published results [100, 186]. The detection of higher 
levels of glucose will be restricted due to the limited concentration of O2 
dissolved in PBS. Therefore, a thin layer of 0.5% Nafion was employed as a 
glucose-limiting membrane, to prevent the enzyme from reacting with the 
excessive glucose molecules. Nafion also acted as an anti-interference 
membrane to prevent the diffusion of electroactive interferents and 
contaminating substances. The proportionate decrease of reduction current 
with the increase in glucose concentration was employed to determine the 
glucose levels using the amperometric technique in the presence of oxygen. As 
shown in Fig. 5-2B, the cathodic current decreases with the injection of 
glucose in the range of 0.5-32 mM. The use of Nafion in the Nafion/APTES-
GOx/GCE enabled the successful determination of glucose concentration in 
the entire pathophysiological range. 
 
Fig. 5-2. The (A) cyclic voltammograms  and  (B) amperometric response  of 
the developed glucose biosensor for varying glucose concentrations (0.5-32 
mM) in 50 mM PBS in the presence of oxygen. The scan rate in (A) was 100 
mV s-1, while the applied potential in (B) was -0.45 V. 
 
5.3.2 Detection of glucose and blood glucose  
The assay curve obtained from the current-time curves (Fig. 5-3A) 
demonstrates that the developed electrochemical glucose biosensor can detect 
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commercial glucose in the dynamic range of 0.5-48 mM at an applied 
potential of -0.45 V. The glucose sensing results obtained by the developed 
procedure were better than those obtained by various glucose sensing 
(including non-enzymatic [26, 211]  and enzymatic [212, 213]) approaches. 
 
Fig. 5-3. Detection of (A) commercial glucose, and (B) Sugar-Chex blood 
glucose linearity standards by the simple and rapid glucose biosensor. The 
error bars shown in (A, B) represent SD. 
  
The developed biosensor was further evaluated for the detection of blood 
glucose in Sugar-Chex whole blood glucose linearity standards (Fig. 5-3B).  
The biosensor detected the entire range of Sugar-Chex blood glucose linearity 
standards i.e. 1.3-28.2 mM, which coveres the entire pathophysiological range 
in diabetics as detected by most commercial glucose meters. Additionally, the 
current signal for the detection of 8 mM Sugar-Chex blood glucose was about 
2.2-fold higher than that for the detection of 8 mM commercial glucose. As 
discussed previously, Sugar-Chex blood glucose linearity standards highly 
mimic the flow rate, hematocrit, viscosity, and surface tension of fresh human 
whole blood, they provide more reliable readings in comparison to 
commercial glucose [165, 188]. 




Fig. 5-4. The effect of interfering substances on the detection of blood glucose 
by the glucose biosensor. The error bars represent SD. 
 
The effect of common interfering substances such as bilirubin, creatinine 
and uric acid, and medications such as acetaminophen, ibuprofen and 
tetracycline on the detection of blood glucose was studied (Fig. 5-4). The 
testing concentrations of these interfering substances were 10-40 folds higher 
than their physiological or therapeutic levels [214]. About 8% interference 
was observed by the injection of uric acid, salicylate and tolbutamide, while 
less than 4% interference was observed for ascorbic acid. Dopamine and 
bilirubin only provoked negligible signal response. However, there was no 
detectable interference by these substances at their physiological or 
therapeutic levels (data not shown). These results were not totally unexpected 
as most of electroactive interfering substances are not detected at -0.45 V. The 
developed mediatorless approach eliminated any plausible interaction between 
the mediator and electroactive interferents. Finally, the negatively charged 
Nafion membrane also circumvented the diffusion of electroactive negatively-
charged substances to the sensing area of the biosensor. Moreover, the effect 
of therapeutic levels of non-glucose sugars such as lactose, maltose and xylose 
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was also investigated. No interference from any of these sugars was observed. 
Therefore, our strategy holds tremendous potential for highly precise blood 
glucose monitoring in diabetics with remarkable selectivity, which is one of 
the most critical factors for the development of commercial glucose meters [5, 
192-195, 215]. 
5.3.4 Biosensor performance of the simple and rapid glucose sensing 
strategy 
    The production reproducibility (Fig. 5-5A) and the anti-biofouling behavior 
(Fig. 5-5B) of developed glucose sensing procedure were also investigated. 
The current signals corresponding to the detection of 8 mM glucose by 25 
different GOx-bound GCEs were highly reproducible as the percentage 
coefficient of variance was only 3%. The anti-biofouling performance of the 
developed GOx-bound GCEs was excellent as the current signal for the 
detection of 8 mM glucose by a particular electrode was stable for five days. 
Therefore, the developed GOx-bound GCEs have the same anti-biofouling 
performance as found in commercially-available CGMS, where the GOx-
bound electrodes are used continuously for five days. The total concentration 
of GOx bound to GCE, as determined by BCA protein assay [216], was found 
to be consistently uniform for about three months (Fig. 5-5C), which 
confirmed the leach-proof binding of GOx to GCE by the proposed 
bioanalytical procedure. The stability of the developed GOx-bound GCEs was 
also studied under four different storage conditions that are employed 




Fig. 5-5. (A) Production reproducibility of the developed simplified procedure 
for the preparation of Nafion/APTES-GOx/GCEs. (B) Effect of biofouling on 
the electrochemical sensing of glucose by the developed glucose biosensor. (C) 
BCA protein assay for the determination of GOx bound to the Nafion/APTES-
GOx/GCEs for 12 weeks. The error bars shown in (A, B, C) represent SD. 
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The biosensor was most stable when stored at RT in the dry state since there 
was no decrease in the sensing signal for about four weeks. The storage at 4 ºC 
in the dry state was not good as the response signal kept decreasing constantly 
with time and reached 50% of its initial value after about five weeks. On the 
other hand, the stability of the developed GOx-bound GCEs stored in PBS at 
RT or 4 ºC was quite similar but not better than that stored at RT in dry state. 
One possible explanation to this observation is that there may be changes in 
the conformation of GOx under different storage conditions, which affects its 
functional activity. It has also been clearly demonstrated that the stability of 
the developed GOx-bound GCE can be highly affected by the storage 
condition. The performance of our approach is comparable to the GOx-
entrapped poly(vinyl alcohol) modified platinum electrode40, which could 
also detect up to 37 mM glucose at -0.6 V vs. saturated calomel electrode and 
maintains 87% of the initial sensing signal after 35 days when stored in the dry 
state at RT. However, our strategy employs a simple and the most rapid 
procedure for preparing GOx-bound electrode in comparison to 48 h for the 
preparation of polymer membrane [217]. Therefore, the developed procedure 
has immense potential for the simple and rapid preparation of enzyme-bound 
electrodes for the electrochemical detection of other analytes in biomedical 
diagnostics, environmental monitoring and industrial settings. Moreover, this 
procedure can be easily extended to other electrode materials such as screen 
printed carbon, graphene, and carbon nanotubes. 
5.4 Conclusions 
In this study, a rapid and simple procedure was developed for the 
preparation of a highly stable and leach-proof GOx-bound GCE. Crosslinked 
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GOx via glutaraldehyde was drop cast on a KOH-pretreated GCE followed by 
drop-casting of APTES to form a stable bioactive layer.  At -0.45 V, the 
biosensor exhibited a wide dynamic detection range of 0.5-48 mM for 
commercial glucose and 1.3-28.2 mM for Sugar-Chex blood glucose linearity 
standards. Several endogenous electroactive substances, drug metabolites and 
non-glucose sugars commonly found in blood were tested and provoked 
negligible signal response. Moreover, non-glucose sugars did not interfere the 
glucose sensing by the developed biosensor. To our knowledge, the developed 
procedure is the most rapid method for preparing glucose biosensor. The 
biosensor suffered no biofouling after 7 days of immersion in Sugar-Chex 
blood glucose. With excellent production reproducibility, GOx-bound 














Chapter 6 Graphene versus multi-walled carbon nanotubes for 
electrochemical glucose biosensing 
6.1 Introduction 
    Graphene has been widely used for the development of optoelectronic 
devices [166], super capacitors [167] and various types of high performance 
sensors [168-172] due to its high surface-area-to-volume ratio [55, 174], 
excellent electrical conductivity and high electron mobility [175]. Graphene, 
with a large surface area, enhances the loading of biomolecules by passive 
adsorption or covalent crosslinking, while its excellent conductivity and small 
band gap are beneficial for the conduction of electrons between the 
biomolecule and the electrode surface [175]. It has been claimed that graphene 
may not be beneficial as an electrode material, due to its lower edge surface 
area, leading to slow heterogeneous electron transfer [218]. The surface 
coverage and orientation of graphene on the electrode may also significantly 
affect its electrochemical performance [219]. 
    It is of considerable interest to evaluate if graphene is advantageous 
compared to CNTs in various applications; particularly, in electrochemical 
biosensing for glucose, since the latter, with a high surface-volume ratio, has 
been extensively used in the development of super capacitors [220-222], 
energy storage devices [223], environmental sensing devices [224, 225], drug 
delivery systems [57], biosensors [56, 226] and other devices. The literature 
also offers several reviews discussing the comparison of graphene- and CNT-
based electronic devices [222, 227, 228], hydrogen physical adsorption [229], 
chemical sensors/biosensors [230] and fuel cells [231]. The thermal properties 
[232], energy dispersion [233], electrical properties [234, 235] and 
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photocatalytic properties [236] of these materials have also been compared. 
However, there are only a few reports where graphene and CNT-based 
electrodes are compared for various biosensors [237-239], and to our 
knowledge, there is no comparison of graphene- and MWCNT-based 
electrodes for electrochemical glucose biosensing with respect to direct 
electron transfer. 
This study describes a simple procedure for the fabrication of the graphene- 
and MWCNT-based electrochemical glucose biosensors using GOx (Fig. 6-1). 
The GOx covalently bound to graphene- or MWCNT-based electrodes will be 
evaluated for its DET with the underlying electrode. The analytical 
performance of both biosensors will also be compared with respect to 
detection limit, linearity and interference caused by potential interfering 
substances and drug metabolites at normal and extreme physiological levels. 
 




6.2 Preparation of graphene- and MWCNT-based glucose biosensors 
The GOx stock solution, prepared by mixing equal volumes of 20 mg mL-1 
GOx and 5% glutaraldehyde, was stored overnight at 4 °C before use. The 
polished GCEs were dipped in 1% KOH for 5 min to generate hydroxyl 
groups on their surface. Two microliters of 2 mg mL-1 graphene or MWCNTs 
(dispersed in 0.25% APTES) were drop-cast on the GCE followed by 
immediate drop-casting of 2 µL of EDC activated-GOx (10 mg mL-1 GOx was 
mixed with 0.12 g mL-1 EDC in the volumetric ratio of 30:2 for 15 min at RT 
just before use). The graphene-GOx/GCE and MWCNTs-GOx/GCE were 
dried at RT for 1 h and washed extensively with 50 mM PBS. Thereafter, they 
were drop-cast with 3 µL of 0.5 % Nafion, dried at RT for 10 min and washed 
extensively with 50 mM PBS to form Nafion/graphene-GOx/GCE and 
Nafion/MWCNT-GOx/GCE. Nafion/graphene/GCE and 
Nafion/MWCNT/GCE were also prepared and employed as control. 
6.3 Results and discussion 
6.3.1 Development of graphene- and MWCNT-based glucose biosensors 
In this study, APTES was used for dispersion, as well as surface 
modification for graphene [128] and MWCNTs [58]. GOx-bound graphene- or 
MWCNT-functionalized GCEs were prepared by a simple procedure (Fig. 6-1) 
and employed for mediatorless amperometric glucose biosensing. In brief, the 
procedure was based on the initial binding of the alkoxy groups of APTES to 
the hydroxyl groups on the KOH-treated GCE and graphene/MWCNTs. The 
treatment of a thin cell GCE (3 mm in diameter, BASi, MF-1000, West 
Lafayette, IN, USA) with KOH resulted in a slight increase in oxygen content 
associated with the formation of hydroxyl. SEM-EDX analyses revealed that 
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the KOH-treated GCE exhibited 94.8% C and 5.2% O, compared to 95.5% C 
and 4.5% O obtained for the untreated GCE. The dispersion of 
graphene/MWCNTs in APTES leads to their functionalization with APTES, 
while the unbound APTES molecules also functionalize the GCE surface. 
Thereafter, the formation of siloxane bonds (–Si–O–Si–) between the APTES 
molecules conjugated on graphene/MWCNTs and on the GCE leads to the 
preparation of graphene-/MWCNT-functionalized GCE. This is followed by 
the subsequent crosslinking of the free amino groups of APTES on the 
graphene-/MWCNT-functionalized GCE to the EDC-activated GOx. Finally, 
the graphene-GOx/GCE and MWCNT-GOx/GCE were covered with 0.5% 
Nafion to serve as a glucose limiting membrane. 
 
Fig. 6-2. High resolution images of (A) graphene-GOx, (B) Nafion/graphene-
GOx, (C) MWCNT-GOx and (D) Nafion/MWCNT-GOx modified glassy 
carbon substrates using HIM. The scale bars for (A)/(B) and (C)/(D) are 10 





Fig. 6-3. Raman spectra of (a) APTES-functionalized and (b) pristine 
graphene. The Raman shift range is 1000~3500 cm-1, 1300~1650 cm-1, and 
2300~3500 cm-1 for (A), (B), and (C). 
 
 
Fig. 6-4. Raman spectra of (a) APTES-functionalized and (b) pristine 
MWCNTs. The Raman shift range is 1000~3500 cm-1, 1300~1650 cm-1, and 
2300~3500 cm-1 for for (A), (B), and (C). 
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The carbon material-enzyme mixtures (Fig. 6-2A and C) were spread 
uniformly on glassy carbon. The coating of carbon material-GOx mixtures 
with Nafion changed their appearance (Fig. 6-2B and D), which confirmed 
the covering of the carbon material-GOx functionalized GCEs with a Nafion 
thin layer. As described in Fig. 6-3 and Fig. 6-4, Raman signatures of pristine 
MWCNTs (and graphene) exhibit peaks near 1350, 1580, 1620, 2450, 2700, 
3168 and 3238 cm−1, known as D, G, D′, G*, 2D, D+G and 2D′ peaks, 
respectively. These are characteristics of defects and atomic vibrations in the 
carbon network [240, 241]. However, the Raman spectrum of APTES 
functionalized MWCNTs (and graphene) shows a red-shift (i.e., peaks shift to 
lower energy) of all the characteristic peaks, suggesting an n-type doping of 
MWCNTs (and graphene), revealing the functionalization of the carbon 
materials by APTES [242]. The red-shift observed in graphene was 
comparatively lesser than in MWCNTs. This may not be due to electron/hole 
doping, but a possible tiny-change in the effective mass of the graphene unit 
cell in APTES functionalized graphene. Nevertheless, the red-shift in the 
Raman signatures of graphene itself is suggestive of functionalization by 
APTES. 
The reaction intermediate of each step in Fig. 6-1 was also characterized by 
FTIR to confirm the immobilization of GOx on such modified electrodes. The 
KOH-treated GCE (3 mm in diameter, BASi, MF-1000, West Lafayette, IN, 
USA) functionalized with APTES exhibited several important FTIR bands, 
including 1556 and 1484 cm−1 (ν(NH2)), 1433 cm−1 (νs(CH3)), 1383 cm−1 
(νas(CH3)) and 1371 cm−1 (ν(CH2 backbone)). Further modification of this 
electrode with MWCNTs (dispersed in DMF) shows new FTIR bands at 1141 
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cm−1 (νas(C-O)), 2976 cm−1 (νs(CH2)) and 3015 cm−1 (νas(CH2)), which could 
be attributed to defect sites on the CNT surface (Fig. 6-5, curve a). This FTIR 
signature was identical to the one obtained for the GCE modified with 
MWCNTs dispersed in APTES (Fig. 6-5, curve b). Fig. 6-5 (curve c) shows 
the characteristic amide I and amide II bands of GOx centered at 1655 cm−1 
and 1535 cm−1, the most compelling evidence for the immobilization of GOx 
on the MWCNT/APTES-functionalized GCE. 
 
Fig. 6-5. The FTIR spectrum of (a) the KOH-treated GCE modified with 
APTES and MWCNTs dispersed in DMF; (b) the KOH-treated GCE modified 
with MWCNTs dispersed in APTES; (c) same as (b) followed by conjugation 
with GOx. 
 
The FTIR spectra for graphene deposited on GCE (pretreated with KOH) 
using a solution of graphene dispersed in APTES or layer by layer APTES 
then graphene in DMF were very similar (Fig. 6-6 curves a and b). No 
significant peak was observed for graphene, except for two small peaks at 
1565 (skeletal vibration of graphene sheet) and 1150 cm−1. Similar features for 
Si–O–C and Si–O–Si bonds were found in the 1000–1100 cm−1 range. When 
GOx activated with EDC was added to the composite, the presence of bands at 
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1638 and 1521 cm−1 confirmed that GOx was bound to the APTES through 
amide linkages (Fig. 6-6 curve c). 
 
Fig. 6-6. The FTIR spectrum of (a) the KOH-treated GCE modified with 
“layered by layered” APTES and graphene dispersed in DMF; (b) the KOH-
treated GCE modified with graphene dispersed in APTES; and (c) same as (b) 
followed by conjugation with GOx. 
 
6.3.2 Evaluation of direct electron transfer 
    CV was performed on the graphene- and MWCNT-functionalized GCEs at 
varying scan rates (20-200 mV s−1) in 5 mM K3Fe(CN)6 (in 0.5 M KCl) (Fig. 
6-7). The Ep remained almost unchanged at varied scan rates for both 
electrodes. The Ipc and Ipa plotted against the square root of the scan rate was 
linear, confirming the reversible redox reaction of the Fe(CN)63−/Fe(CN)64− 
couple on graphene- and MWCNT-functionalized GCEs. For a reversible 
process [243]: 
Ip = (2.69 × 105) n3/2 A DO1/2 v1/2 CO*                                (6-1) 
Where Ip is peak current, n is the number of electrons transferred, A is the 
effective area, DO is the diffusion coefficient of Fe(CN)63−, v is the scan rate, 


















KCl, n = 1, DO = 7.6 × 10-6 cm2 s−1, while the effect surface area of the 
graphene/GCE and the MWCNT/GCE was estimated to be 0.072 and 0.11 cm2, 
respectively. 
 
Fig. 6-7. CVs of (A) graphene- and (C) MWCNT-functionalized GCE at 
different scan rate in 5 mM Fe(CN)63-. Scan rate: 20-200 mV s-1. (B) and (D): 
Linear relation between Ip and v1/2 (B: graphene-GCE; D: MWCNT-GCE).  
 
Fig. 6-8A shows the CVs of Nafion/GOx/GCE (dot), Nafion/graphene/GCE 
(solid), Nafion/MWCNT/GCE (dash dot), Nafion/graphene-GOx/GCE (long 
dash-short dash) and Nafion/MWCNT-GOx/GCE (dash dot dot) in N2-
saturated 50 mM PBS at 100 mV s−1. Rectangle-shaped CVs were observed on 
the Nafion/graphene/GCE (solid) and the Nafion/MWCNT/GCE (dash dot) in 
the applied potential range. The double-layer capacitance of 
Nafion/MWCNT/GCE was significantly greater than Nafion/graphene/GCE.  
The redox peaks of FAD/FADH2 were not observed for Nafion/graphene-
GOx/GCE (long dash-short dash). In contrast, a pair of well-defined redox 
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peaks was observed on the Nafion/MWCNT-GOx/GCE (dash dot dot) with 
the Epc of −0.49 V and the Epa of −0.42 V. Therefore, the formal potential (E0) 
was −0.455 V, which reflects the typical electrochemical characteristics of 
GOx immobilized on CNT-based electrodes in neutral solution [146, 244]. 
The cathodic peak is attributed to the reduction of FAD to FADH2, while the 
anodic peak is due to the reversible re-oxidization of FADH2 to FAD [100]. 
The DET of GOx observed on the MWCNT-modified electrode may be 
facilitated by the three dimensional structure of MWCNTs that results in a 
shortened tunneling distance for the electron transfer between the enzyme and 
the underlying electrode surface [100]. As the electrochemical property or the 
structure of commercial graphene is very different from that of MWCNTs, the 
DET between GOx and the electrode surface cannot be observed by the simple 
CV approach. 
The scan rate effect on the electrochemical response on Nafion/MWCNT-
GOx/GCE is shown in Fig. 6-8B. Notice that two separate reduction peaks 
were observed on the electrode at about −0.3 V and −0.47 V at 20 and 50 mV 
s−1. The reduction peak at about −0.47 V should be due to the reduction of 
GOx-FAD to form GOx-FADH2, but the unexpected one at −0.3 V may be 
owing to the metallic impurity in MWCNTs. Indeed, the reduction peak at 
−0.3 V was also observed on the Nafion/MWCNT/GCE (Fig. 6-8A). However, 
only the reduction peak of GOx-FAD was observable at scan rates higher than 
50 mV s−1 (100, 150 and 200 mV s−1). The linear increase of Ipc and Ipa with 
increasing scan rate from 20 to 200 mV s−1 confirmed the excellent 
electrocatalysis of MWCNTs and the redox reaction of FAD/FADH2 couple 




Fig. 6-8. (A) CVs of various modified electrodes in N2-saturated PBS at 100 
mV s−1; (B) The effect of scan rate (20, 50, 100, 150 and 200 mV s−1) on the 
DET of GOx on Nafion/MWCNT-GOx/GCE in N2-saturated PBS. Inlet: the 
linear relation between Ipc (or Ipa) and v; (C) The relation between the E0 
(observed on Nafion/MWCNT-GOx/GCE) and different pH values: 5.65, 6.36, 
7.2, 7.72, 8.29. v = 100 mV s−1; (D) Plot of Ep (of the Nafion/MWCNT-
GOx/GCE) vs. log v, v = 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, 0.9, 1.1, 1.3, 1.5, 1.7, 1.9 
V s−1. Inlet: the relation between Epa (or Epc) and log v. 
 
The pH effect on the electrochemical behavior of GOx at the 
Nafion/MWCNT-GOx/GCE was also studied, as shown in Fig. 6-8C. The 
formal potential of the Nafion/MWCNT-GOx/GCE varied linearly with pH, 
varying from 5.65 to 8.29. The slope of the formal potential vs. pH was −51.6 
mV/pH, close to the theoretical value of −59 mV/pH for a two-electron 
coupled with two-proton redox reaction [244], as shown in Eq (6-2). The 
charge transfer coefficient, α, and the heterogeneous transfer rate constant, ks, 




GOx-FAD + 2e− + 2H+ ↔ GOx-FADH2                                            (6-2)  
log𝑘𝑠 = 𝛼 log(1 − 𝛼) + (1− 𝛼)log𝛼 − log 𝑅𝑇𝑛𝐹𝑣 − 𝛼(1− 𝛼)𝑛𝐹∆𝐸𝑝2.3𝑅𝑇  (6-3) 
where n is the number of electrons transferred in the rate-determining reaction, 
ΔEp is the peak-to-peak potential difference and v is the scan rate. The plot of 
Ep vs. log v (Fig. 6-8D) exhibited two straight lines with a slope of 
−2.3RT/αnF and 2.3RT/(1−α)nF for the cathodic and anodic peaks, 
respectively. The average value of α and ks was calculated to be 0.59 and 2.05 
s−1, respectively. The ks is higher than the results reported for GOx 
immobilized in CNTs (1.78 s−1 [249] and 1.69 s−1 [250]) or gold nanoparticle 
incorporated matrices (1.69 s−1 [251]). 
6.3.3 Evaluation of glucose oxidation  
In N2-saturated glucose solution, the cathodic currents of Nafion/graphene-
GOx/GCE decreased with increasing glucose concentration from 0 to 8 mM 
(Fig. 6-9A). In contrast, both the Ipc and Ipa of Nafion/MWCNT-GOx/GCE 
increased when glucose was increased from 0 to 8 mM (Fig. 6-9B). The 
increase of Ipc suggested that the direct electrochemical reduction of FAD to 
FADH2 was enhanced with the increase in glucose concentrations, resulting in 
the build-up of FADH2 that led to increased Ipa. According to a previous report, 
only increasing Ipa of GOx is observed on the GCE decorated with a hollow 
structured polymer-nickel oxide composite [100].  
The cathodic currents of Nafion/graphene-GOx/GCE for various glucose 
concentrations under air-saturated condition (Fig. 6-9C) exhibited a similar 
tendency to those under the N2-saturated condition. The elucidation of an 
exact mechanism for the electrochemistry of GOx on Nafion/graphene-
GOx/GCE in the absence and presence of oxygen requires further research 
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efforts. In contrast, the cathodic peak currents decreased with the increase in 
glucose concentration on Nafion/MWCNT-GOx/GCE (Fig. 6-9D), which may 
be due to the GOx-catalyzed oxygen reduction on the GCE [100, 245]. The 
reduction wave corresponds to the FADH2-GOx catalyzed reduction of O2. As 
O2 is consumed by FADH2, its concentration at the electrode surface is 
reduced, resulting in the decrease in reduction current with the increase in 
glucose concentration. Nevertheless, the Ipa did not change appreciably for 
various glucose concentrations. Without the enzyme, the control electrodes, 
i.e., Nafion/graphene/GCE and Nafion/MWCNT/GCE, did not show any 
change in the current signal with varying glucose concentration, both in the 
absence and presence of O2 (data not shown). 
 
Fig. 6-9. CVs of (A, C) Nafion/graphene-GOx/GCE and (B, D) 
Nafion/MWCNTs-GOx/GCE in PBS containing 0, 1 and 8 mM glucose in the 




6.3.4 Amperometric detection of commercial and blood glucose 
As both in vivo and in vitro blood samples contain dissolved oxygen, the 
decrease of the cathodic current on Nafion/graphene-GOx/GCE and 
Nafion/MWCNT-GOx/GCE can be used to detect glucose by the 
amperometric I–t curve in the presence of O2. The Nafion coating was 
employed to circumvent limited oxygen concentration in PBS, as it acts as a 
glucose limiting membrane to prevent excess glucose molecules from being 
converted by GOx. The optimum applied potential was −0.45 V (data not 
shown). Fig. 6-10A illustrates the amperometric response of the MWCNT-
based electrode for detecting 0.5~32 mM commercial glucose. Fig. 6-10B 
shows the assay curves for glucose detection by GOx-bound graphene- and 
MWCNT-functionalized GCEs. Both electrodes exhibited dynamic responses 
to varying glucose concentrations up to 16 mM. However, the current 
response of commercial glucose detected by Nafion/MWCNT-GOx/GCE 
was >2-fold higher than that of Nafion/graphene-GOx/GCE. Considering the 
higher effective surface area of MWCNT/GCE (0.11 cm2) versus 0.072 cm2 
for graphene/GCE, GOx apparently exhibited higher activity on the 
Nafion/MWCNT substrate. Note that the glucose linear range for both 
graphene- and MWCNT-based glucose biosensors was 0.5–4 mM. The 
detailed comparison between this work and recently reported graphene- and 
CNT-based glucose biosensors is shown in Table 6-1. 
The Sugar-Chex whole blood glucose linearity standards from Streck were 
employed to evaluate the sensing performance of the developed biosensors for 
the detection of blood glucose. Both the developed electrodes were able to 
detect 1.4–27.9 mM glucose that covers the entire pathophysiological range of 
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glucose in diabetics (Fig. 6-10C). However, the current response for the 
Nafion/MWCNT-GOx/GCE was >4-fold higher than that of Nafion/graphene-
GOx/GCE, thereby illustrating the superior analytical performance of 
MWCNTs for the development of electrochemical glucose biosensor. The 
higher current signal provided by Nafion/MWCNT-GOx/GCE could be 
attributed to the larger effective surface area of MWCNT/GCE that leads to 
higher GOx immobilization. 
Fig. 6-10. (A) The amperometric response of Nafion/MWCNT-GOx/GCE for 
the detection of 0.5 to 32 mM glucose at −0.45 V in the presence of O2; (B) 
Assay curves for the detection of commercial glucose by the graphene- and 
MWCNT-based electrodes; (C) Assay curves for the detection of Sugar-Chex 
whole blood glucose linearity standards by both electrodes; (D) The effect of 
interfering substances on the electrochemical detection of 6.8 mM blood 


















Detect 1.4–27.9 mM blood 
glucose in diluted Streck 
samples 
No interference from physiological 





4 × 10−4–2 
Detect 5 and 10 mM glucose 
added into serum samples 
No interference from 2 mM ascorbic 
acid, uric acid, citric acid and 





modified with Fe3O4, 
polyaniline and GOx 
1–1.4 
Detect blood glucose  
(0.2–1.4 mM) in diluted serum 
samples 
No interference from 0.3 mM ascorbic 
acid and uric acid and  
0.01 mM immunoglobulin G; not testing 






1 × 10−3–1 
Detect blood glucose in diluted 
blood samples (recovery: 
92.5%–105.3%) 
No interference from 0.2mM ascorbic 
acid and 0.5 mM uric acid; not testing 






Detect 1.4–27.9 mM blood 
glucose in diluted  
Streck samples 





A mixture of GOx 
and a CNT film 
sandwiched with  
10 nm thick PPFs 
0.025–2.2 Not testing for real samples 
No interference from  
0.5 mM ascorbic acid 
[254] 
Incorporation of GOx 
into the colloidal Au-
CNT composite 
matrix 
0.05–1 Not testing for real samples  
No interference from 1 μM cysteine and 
0. 1 μM uric acid; significant 
interference from 1 μM ascorbic acid; 





titania nanotube array 
modified electrode 
6 × 10−3–1.5 Not testing for real samples  




6.3.5 Effect of interfering substances 
    The interference was determined as the percentage of the current signal, 
obtained for detecting a specific concentration of blood glucose, which was 
contributed by the addition of a particular interfering substance. The 
interfering substances with pathophysiological concentrations, about 2~20-
fold higher than their physiological concentrations, did not induce any 
considerable interference to the electrochemical detection of 6.8 mM blood 
glucose by Nafion/graphene-GOx/GCE. Bilirubin (0.34 mM) or 3.7 mM 
tolbutamide only induced less than 5.2% interference, while 3.62 mM 
salicylate, as well as 3.21 mM tolazamide induced about 4% interference. 
Except for 0.5 mM ephedrine, the remaining interfering species only resulted 
in <3% error in the detection of blood glucose. However, there was no 
interference from these interfering substances at their physiological 
concentrations (Fig. 6-10D). For Nafion/MWCNT-GOx/GCE, the 
pathophysiological concentrations of interfering substances and drugs caused 
appreciable interferences, resulting in higher current signals (data not shown). 
However, the interference was significantly reduced when such interfering 
substances were tested at their corresponding physiological levels (Fig. 6-
10D). Bilirubin (20.4 μM) and 0.68 mM ascorbic acid only induced about 3.6% 
interference, compared with 4% for 0.37 mM tolbutamide. There was no 
interference from 0.13 mM creatinine, while 0.132 mM acetaminophen and 
0.5 mM ephedrine, the remaining interfering substances, had about less than 
2.5% interference. The effect of therapeutic levels of interfering substances on 
the graphene- and MWCNT-base biosensors is summarized in Table 6-2. 
Work is in progress to investigate long-term storage stability, anti-biofouling, 
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production reproducibility and robustness of functional GOx immobilization 
of the graphene- and MWCNT-based glucose biosensors. 
Table 6-2. The effect of therapeutic levels of interfering substances on the 













Ascorbic acid 0.68 1.04 3.57 
Uric acid  0.42 0.73 2.4 
Acetaminophen  0.132 0.21 0 
Dopamine  0.1 0.24 1.35 
Salicylate  2.2 1.49 1.08 
Creatinine  0.13 0.1 0 
Bilirubin  2.04 × 10-2 0.52 3.55 
Tetracycline  9 × 10-3 0.5 2.15 
Ibuprofen  0.2 0.21 1.36 
Tolazamide  8 × 10-2 1.04 0 
Tolbutamide  0.37 0.51 4.14 
Ephedrine  0.5 0 0 
Galatose  1.11 0.54 1.38 
Lactate  1.78 0 0 
Lactose   0.58 0 0 
Maltose  2.92 0 2.09 
Xylose  3.86 0 0 
* Effect of interfering substances on blood glucose sensing = (total Isteady of 6.8 mM 
Streck glucose and particular concentration of an interfering substance) - Isteady of 6.8 





The graphene- and MWCNT-based glucose biosensors were developed 
using a simple and rapid bioanalytical procedure. The DET of GOx was only 
observed by CVs in the case of MWCNTs, due to their electrocatalytic 
property. Nafion/MWCNT-GOx/GCE also provided >2- and 4-fold higher 
signals for commercial and blood glucose, respectively, in comparison to 
Nafion/graphene-GOx/GCE. The higher signal enhancement by MWCNTs 
may be due to their larger surface area, which leads to higher GOx loading. 
The exact molecular mechanism responsible for this behavior needs to be 
elucidated by further intensive research endeavors. Interfering substances and 
drug metabolites at their physiological concentrations exhibited no significant 
interference with the blood glucose determination in both biosensors. 
Apparently, MWCNTs served as a better electrode material compared to 
graphene for electrochemical glucose sensing using our developed biosensors. 
Notice also that some impurities in MWCNTs, particularly iron particles, can 
catalyze the oxidation of glucose. However, the electrochemical reaction of 
glucose only occurs at extreme alkali pH, e.g., in 0.1 M NaOH at >0.5 V 
applied potential [257]. Notice also that nanographite impurities in CNTs are 
also responsible for the electrochemical oxidation of tyrosine, tryptophan and 
NADH [258]. Again, the applied potential must be over +0.5 V vs. Ag/AgCl. 
Therefore, such impurities are not expected to cause any significant 
interference in the direct electron transfer between GOx, and the underlying 






Chapter 7 Conclusions and Recommendations 
    This study investigated in depth the concentration effect of APTES on three 
mediatorless electrochemical glucose sensing formats with and without using 
MWCNTs, in which APTES served as surface functionalization and/or 
dispersion agent. It was clearly demonstrated that the optimization of APTES 
concentration was the most critical step for constructing an electrochemical 
glucose biosensor employing APTES, as it considerably influenced the current 
response in glucose sensing. Additionally, MWCNT (dispersed in DMF) 
format, the most suitable strategy for blood glucose monitoring in diabetes 
was screened out from the three proposed formats. This format also exhibited 
wider dynamic glucose linearity than the reported glucose biosensors utilizing 
MWCNTs. APTES based surface functionalization is widely employed for the 
development of electrochemical glucose biosensors and other bioanalytical 
applications. However, varying APTES concentrations have been randomly 
used due to the absence of systematic study which demonstrates the significant 
effect of APTES concentration on the analytical performance. The present 
study fills this gap and provides a guided insight into the optimization of 
APTES-based chemistry applied in electrochemical glucose biosensor. 
    This study also constructed a mediatorless amperometric glucose biosensor 
by covalent binding GOx to an APTES-graphene functionalized electrode. It 
was found that this biosensor was able to detect commercial glucose and blood 
glucose in the diabetic pathophysiological range without being interfered by 
physiological substances, drug metabolites and non-glucose sugars. This may 
be attributed to the low applied potential of -0.45 V and the negatively charged 
Nafion membrane. The difference in the FTIR spectra of pristine graphene and 
104 
 
APTES-graphene mixture indicates the interaction between graphene and 
APTES to form a stable complex on the electrode surface. An important 
contribution of this strategy is that it first demonstrates the utilization of 
APTES in dispersing and functionalizing graphene for the fabrication of 
mediatorless glucose biosensor in less than 3 h. The experimental result also 
suggests the excellent production reproducibility of this strategy. Therefore, 
the preparation method of the APTES-graphene-GOx electrode could be easily 
transduced to screen-printing that may enable the cost-effective mass 
production of biosensor for commercialization. 
    A rapid and highly simplified strategy for the preparation of a stable and 
leach-proof GOx-bound electrode was also proposed in this study. The 
constructed glucose biosensor exhibited superior sensor capability in terms of 
wide linearity toward glucose sensing (i.e. 0.5-48 mM), excellent anti-
biofouling performance, robust enzyme binding on electrode surface and high 
sensor stability. It was found that the proposed glucose biosensor could 
reserve its initial activity for at least four weeks when it was stored at room 
temperature in dry state. To the best of our knowledge, this is the most rapid 
method compared to the reported strategies for preparing mediatorless glucose 
biosensors so far. This study for the first time has compared the long-term 
activity of a glucose biosensor in different storage conditions (4 °C in PBS), 
4 °C in dry state, RT in PBS and RT in dry state). It has proved that the 
optimum storage condition to preserve the sensor activity was RT in dry state 
rather than 4 °C (in PBS or dry state) which usually was employed by most 
studies. This study is also the first to use Streck blood glucose standard to 
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demonstrate the anti-biofouling capability of a glucose biosensor for seven 
days. 
    This study also critically compared the sensor performance of 
electrochemical glucose biosensors fabricated by using MWCNTs and 
graphene as electrode materials. A new procedure for preparing nanomaterial-
based glucose biosensor was developed first and then the electrode behavior 
and analytical performance of the MWCNT- and graphene-based glucose 
biosensors were investigated. The CV experiment in nitrogen-saturated buffer 
indicated that the DET between GOx and the electrode surface was only found 
to be significantly promoted by MWCNTs, but no redox peaks of 
FAD/FADH2 group were observed on the graphene-based glucose biosensor. 
Based on comparing the structure of MWCNTs and graphene, we speculate 
that the three dimensional structure of MWCNTs may lead to a shortened 
tunneling distance for the electron transfer between the enzyme and the 
electrode surface. However, the relatively flat morphology of graphene may 
not be beneficial in shortening the tunneling distance. Indeed CNTs and 
graphene are two of the most extensively used carbon-based nanomaterials. It 
would be of considerable interest to evaluate if graphene may be more 
advanced than CNTs in various applications. Although a few reports have 
compared graphene and CNTs as electrode materials in developed biosensors, 
this study is the first report that compares their glucose sensing performance. 
    It is acknowledged that the detection of glucose by the strategies proposed 
in this study relies on the participation of oxygen. Hence the limited 
concentration of dissolved oxygen may restrict the detection of higher level of 
glucose, according to the equations of GOx catalyzed glucose oxidation. This 
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study has attempted to minimize the influence of oxygen deficit by applying a 
thin layer of Nafion as glucose limiting membrane to prevent excess glucose 
molecules accessing the enzymes. The experimental results indicate that the 
dynamic linearity of each strategy is acceptable after Nafion has been used. 
We also realized that the dependence on oxygen may affect the accuracy in 
glucose measurement error owing to the fluctuation oxygen press. Although it 
seems that the measurements performed in this study were not much affected 
by this problem, we cannot guarantee that similar results could be achieved in 
other laboratories. However, by using oxygen saturated buffer, this 
disadvantage should be considerably minimized. 
    Based on the simplicity of the proposed strategies and the excellent 
performance of the constructed glucose biosensors, this study could be applied 
to analyze the blood glucose levels in real samples. Therefore, future research 
is required particularly in the following directions to make the proposed 
biosensors suitable for diabetic monitoring: 
• The long-term activity, storage stability, anti-biofoulig capability of the 
proposed glucose biosensors need to be monitored and investigated 
further for the development of highly stable GOx-bound electrodes. 
The elucidation of an exact mechanism for the electrochemistry of 
GOx on some proposed glucose biosensors (e.g., Nafion/graphene-
GOx/GCE (Chapter 6)) also requires further research efforts. 
• Although industrial calibration standard has been used to demonstrate 
the practical application of the proposed glucose biosensors, clinical 
blood sample analysis is needed in future to evaluate the capability of 
the proposed biosensors in real sample testing. 
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